{"gene":"CRYAB","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":2015,"finding":"A conserved histidine (His-104) in the ACD dimer interface of HSPB5 controls oligomer structure and chaperone activity in response to acidosis. Destabilization by pH or His-104 mutation shifts the ACD from dimer to monomer and expands oligomer states, producing constitutively activated holdase chaperones that reorganize into structurally distinct client-bound complexes.","method":"In vitro biochemical assays, mutagenesis, structural analysis of dimer interface, chaperone activity assays across pH range","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutagenesis and structural characterization, single lab but multiple orthogonal methods","pmids":["25962097"],"is_preprint":false},{"year":2025,"finding":"HSPB5 wild-type exists in reversible nonactivated (low activity) and activated (high activity) states; disease mutants R120G and D109H are constitutively activated chaperones. The disordered N-terminal regions (NTR) are sequestered from solvent in nonactivated states; mutation or acidic pH causes rearrangements that expose the NTR to enable client binding. Constitutive NTR exposure in mutants leads to increased coaggregation propensity and early cataract.","method":"Hydrogen-deuterium exchange mass spectrometry, native mass spectrometry, chaperone activity assays, mutagenesis of R120G and D109H variants","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal biophysical methods plus mutagenesis and functional assays in a single rigorous study","pmids":["40377988"],"is_preprint":false},{"year":2018,"finding":"Under non-stress conditions, wild-type HSPB5 delays client aggregation solely through transient interactions early in the aggregation pathway, whereas HSPB5 mutants mimicking stress-activated states can also intervene at later aggregation stages, demonstrating state-dependent mechanistic differences in chaperone engagement.","method":"In vitro chaperone activity assays with α-lactalbumin as client, comparison of WT and stress-mimicking mutants under varying conditions","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro reconstitution with defined client, single lab","pmids":["30567736"],"is_preprint":false},{"year":2006,"finding":"The R120G mutant CryAB forms toxic amyloid oligomers (~240–480 kDa) detected by anti-oligomer antibody, whereas wild-type forms only high-molecular-mass species. HSP22 and HSP25 directly interrupt oligomer formation by CryAB R120G; blockade of oligomer formation recovered ubiquitin-proteasomal activity and cellular viability in cardiomyocytes.","method":"In vitro recombinant protein assay, native PAGE, anti-oligomer immunoreactivity, adenoviral transfection in cardiomyocytes, proteasome activity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution plus cell-based validation with multiple orthogonal methods","pmids":["17092938"],"is_preprint":false},{"year":2010,"finding":"HSPB1 (Hsp27) selectively degrades aggregate-prone CryAB mutants (R120G, 450delA, 464delCT) via the ubiquitin-proteasome system. Evidence includes: proteasome inhibitor accumulates mutants; R120G and 450delA accumulate ubiquitin conjugates; HSPB1 knockdown increases polyubiquitin conjugates; HSPB1 overexpression rescue of 464delCT is blocked by proteasome inhibition.","method":"Co-expression in H9c2 cells, HSPB1 overexpression/knockdown, proteasome inhibitor treatment, ubiquitin conjugate detection by immunoblot","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — four independent lines of evidence in cell-based system, single lab","pmids":["20863832"],"is_preprint":false},{"year":2015,"finding":"Co-expression of HSPB1, HSPB4, or HSPB5 itself most effectively prevents aggregation of three HSPB5 mutants (R120G, 450ΔA, 464ΔCT) by competitive incorporation into hetero-oligomers, negating dominant-negative effects; Hsp70 co-expression did not reduce aggregation, indicating the mechanism is oligomer-based rather than general chaperone activity.","method":"Systematic co-expression of all HSPB family members with HSPB5 mutants, aggregation scoring in cells","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — systematic cell-based screen with defined mutants, single lab","pmids":["25961584"],"is_preprint":false},{"year":2009,"finding":"HSF1 regulates p53 protein stability through alphaB-crystallin: hsf1−/− and alphaBcry−/− cells accumulate p53 due to reduced alphaB-crystallin levels. Immunoprecipitated p53R175H from wild-type MEFs pulls down both alphaB-crystallin and Fbx4 ubiquitin ligase, and ectopic Fbx4 increases p53R175H degradation in a mechanism requiring alphaB-crystallin.","method":"Co-immunoprecipitation of p53 with alphaB-crystallin and Fbx4, knockout MEF cell lines, ectopic Fbx4 expression, p53 stability assays","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal pulldown plus genetic KO validation, single lab","pmids":["19343786"],"is_preprint":false},{"year":2011,"finding":"CRYAB associates with both E-cadherin and β-catenin at the cadherin/catenin adherens junction; the alpha-crystallin core domain mediates these interactions. CRYAB overexpression inhibits E-cadherin cytoplasmic internalization and maintains β-catenin at the membrane, reducing downstream cyclin-D1 and c-myc expression.","method":"Co-immunoprecipitation of endogenous E-cadherin and β-catenin with ectopic and recombinant CRYAB; domain mapping; NPC xenograft tumor suppression assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP with domain mapping and in vivo tumor suppression, single lab","pmids":["22158051"],"is_preprint":false},{"year":2019,"finding":"CRYAB physically interacts with β-catenin and protects it from ubiquitination and proteasomal degradation, thereby stabilizing β-catenin and promoting canonical Wnt signaling to enhance osteogenic differentiation of human BMSCs.","method":"Co-immunoprecipitation, in vitro ubiquitination assay, luciferase reporter for Wnt activity, CRYAB overexpression/knockdown in BMSCs, in vivo bone formation assay","journal":"Cell proliferation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus in vitro ubiquitination assay and functional rescue, single lab","pmids":["31638302"],"is_preprint":false},{"year":2024,"finding":"CRYAB interacts with ferritin heavy chain 1 (FTH1) and maintains FTH1 protein stability via the proteasome mechanism in a lactylation-dependent manner; CRYAB knockdown boosts FTH1 degradation, increases cellular iron and ROS, promoting ferroptosis and reducing osteogenic differentiation of BMSCs.","method":"IP-MS to identify CRYAB-interacting proteins, co-immunoprecipitation of CRYAB and FTH1, qRT-PCR, Western blot, ferroptosis assays (Fe/ROS levels, cell viability)","journal":"Aging","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with mechanistic follow-up on proteasomal degradation and lactylation, single lab","pmids":["38787373"],"is_preprint":false},{"year":2016,"finding":"CRYAB interacts with STAT3 and upon sinomenine treatment undergoes nuclear translocation in astrocytes, where it inhibits STAT3 activation and DNA-binding activity, suppressing neuroinflammation downstream of DRD2.","method":"Co-immunoprecipitation of CRYAB with STAT3, electrophoretic mobility shift assay (EMSA) for STAT3 DNA binding, immunofluorescence for nuclear translocation, siRNA knockdown of DRD2 and CRYAB in primary astrocytes","journal":"Journal of neuroinflammation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus EMSA plus localization experiments, single lab","pmids":["27724964"],"is_preprint":false},{"year":2019,"finding":"CRYAB suppresses IKKβ-mediated canonical NF-κB signaling by inhibiting IKK complex formation in intestinal epithelial cells. CRYAB overexpression suppresses pro-inflammatory cytokines (TNF-α, IL-6, IL-1β, IL-8); CRYAB deletion markedly enhances inflammatory responses; TAT-CRYAB fusion protein protects intestinal barrier integrity in colitis models.","method":"Lentiviral overexpression and CRISPR/Cas9 knockout, Western blot for IKK complex, cytokine measurement, in vivo DSS/TNBS colitis with TAT-CRYAB treatment","journal":"Mucosal immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic gain/loss-of-function with defined signaling readout and in vivo rescue, single lab","pmids":["31481750"],"is_preprint":false},{"year":2013,"finding":"αB-crystallin (HspB5) enhances TNF-α-induced NF-κB signaling in endothelial cells, increasing expression of adhesion molecules ICAM-1, VCAM-1, and E-selectin; αB-crystallin-deficient endothelial cells display elevated IκB and incomplete IκB degradation upon TNF-α stimulation, resulting in reduced leukocyte rolling in vivo.","method":"Ectopic expression in endothelial cells, endothelial cells from αB-crystallin-deficient mice, IκB level measurement, in vivo leukocyte rolling assay","journal":"Angiogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout plus gain-of-function with defined signaling and in vivo phenotype, single lab","pmids":["23929007"],"is_preprint":false},{"year":2015,"finding":"Phosphorylation negatively regulates exosomal secretion of cryAB: nonphosphorylated cryAB is preferentially packaged into exosomes, whereas a triple phosphomimetic (3-SD) mutant forms large cytosolic inclusions and shows decreased colocalization with MVE/exosome markers CD63 and Rab27. O-GlcNAcylation of cryAB is required for its exosomal packaging.","method":"YFP-tagged phosphomimetic construct transfection, colocalization with CD63/Rab27 by confocal microscopy, exosome isolation and immunoblot","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phosphomimetic mutagenesis plus organelle colocalization, single lab","pmids":["26620801"],"is_preprint":false},{"year":2015,"finding":"Drosophila CryAB accumulates at Z-bands and around myonuclei, contains a conserved actin-binding domain, and physically interacts with the actin crosslinker Cheerio (filamin) as shown by mass spectrometry and co-immunoprecipitation. CryAB attenuation causes myonuclear clustering and altered sarcomeric actin/Cheerio patterns. Expression of CryAB(R120G) in Drosophila muscle disrupts myofibrillar integrity, produces Z-band breaks, reduces muscle performance, and causes cardiac arrhythmia.","method":"Mass spectrometry, co-immunoprecipitation, muscle-specific RNAi knockdown, transgenic expression of R120G mutant, confocal imaging of sarcomere structure, muscle performance and cardiac phenotype assays","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — MS identification + Co-IP validation + genetic loss-of-function + disease-mutant phenotype, single lab with multiple orthogonal methods","pmids":["25715399"],"is_preprint":false},{"year":2023,"finding":"NUAK kinase phosphorylates Drosophila CryAB at two previously unidentified serine residues conserved in human CryAB sequence. NUAK and CryAB interact physically (yeast 2-hybrid). Loss of NUAK catalytic function causes CryAB aggregation in muscle tissue; a phospho-mimetic NUAK promotes CryAB phosphorylation; mutation of these serines abolishes phosphorylation.","method":"CRISPR kinase-dead mutation, yeast 2-hybrid, phospho-mimetic NUAK construct, phosphosite mutagenesis, in vivo muscle phenotype assay","journal":"Genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast 2-hybrid physical interaction, kinase-dead and phosphosite mutagenesis with in vivo phenotype, single lab","pmids":["37713608"],"is_preprint":false},{"year":2007,"finding":"CryAB protects mechanical (contractile/diastolic) properties of the heart while HSPB2 protects cardiac energetic balance. In genetically modified mice expressing only CryAB (DKO/mCryAB-Tg), ischemia/reperfusion caused impaired ATP/PCr recovery and massive energy wasting upon inotropic stimulation, whereas CryAB-alone hearts showed protection against diastolic dysfunction.","method":"Genetic mouse models (DKO, mCryAB transgenic, DKO/mCryAB-Tg), isolated heart ischemia/reperfusion, 31P NMR spectroscopy of cardiac energetics, contractile performance measurement","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple genetic mouse models with physiological measurements and NMR spectroscopy, distinct roles dissected rigorously","pmids":["17846079"],"is_preprint":false},{"year":2018,"finding":"CRYAB translocates from cytoplasm to nucleus under heat stress and co-localizes with aggregated F-actin, reducing F-actin aggregation. CRYAB overexpression significantly reduces caspase-3-mediated apoptosis in cardiomyocytes exposed to heat stress.","method":"Stable CRYAB-overexpressing H9C2 cell lines, immunofluorescence for CRYAB localization and F-actin, cleaved-caspase 3 Western blot, flow cytometry for apoptosis","journal":"Cell stress & chaperones","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct localization experiment with functional consequence, single lab","pmids":["30246229"],"is_preprint":false},{"year":2017,"finding":"αB-crystallin (HspB5) inhibits intracellular aggregation of α-synuclein when overexpressed in Neuro-2a cells, demonstrated using bicistronic constructs that uncouple sHsp expression from fluorescent tagging to avoid oligomeric structure artifacts.","method":"Bicistronic expression plasmids in Neuro-2a cells, quantification of α-syn inclusion-containing cells by fluorescence microscopy","journal":"Cell stress & chaperones","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — cell-based assay with careful construct design, single lab","pmids":["28337642"],"is_preprint":false},{"year":2019,"finding":"Oxysterol VP1-001 stereoselectively binds to the cryAB dimer (demonstrated by differential scanning fluorimetry and microscale thermophoresis); its enantiomer ent-VP1-001 does not bind and has no therapeutic effect on lens opacity, establishing that stereoselective binding to cryAB dimers is required for reversal of lens opacity in R120G mutant and aged mice.","method":"In silico docking, differential scanning fluorimetry (DSF), microscale thermophoresis (MST), topical treatment of cataract mouse models, transmission electron microscopy","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro binding assays (DSF + MST) combined with in vivo functional stereoselectivity test, single lab with multiple orthogonal methods","pmids":["31369034"],"is_preprint":false},{"year":2024,"finding":"CRYAB mutation p.E105K reduces interaction with cytochrome c and voltage-dependent anion channel (VDAC) as shown by co-immunoprecipitation, impairs OXPHOS assembly and activity, promotes apoptosis, and causes retinal ganglion cell degeneration. Cryab-deficient mice display elevated apoptosis and mitochondrial dysfunctions, establishing CRYAB as a mitochondrial chaperone with antiapoptotic activity in RGCs.","method":"Co-immunoprecipitation of p.E105K mutant and WT CRYAB with cytochrome c and VDAC, OXPHOS complex activity assays, apoptosis assays, Cryab-knockin and knockout mice with retinal phenotyping","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP interaction mapping + OXPHOS assays + two mouse models, single lab","pmids":["39561005"],"is_preprint":false},{"year":2007,"finding":"BRG1 (SWI/SNF ATPase) activates the CRYAB promoter through a 30 bp response element at the edge of a positioned nucleosome; HMGA1 proteins bind an AT-rich sequence within this element both in vitro and in vivo, and HMGA1 target sequences and HMGA1 proteins are required for maximal BRG1-mediated CRYAB promoter activation.","method":"Promoter deletion analysis, chromatin immunoprecipitation (ChIP) for HMGA1 binding in vivo, in vitro binding assay, luciferase reporter assay","journal":"DNA and cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP in vivo plus in vitro binding plus functional promoter analysis, single lab","pmids":["17723105"],"is_preprint":false},{"year":2016,"finding":"KLF4 transcription factor directly binds the CRYAB promoter and upregulates CRYAB expression in osteosarcoma cells, promoting cell proliferation and migration via CRYAB.","method":"Chromatin immunoprecipitation (ChIP) of KLF4 at CRYAB promoter, luciferase reporter assay, KLF4 overexpression/knockdown with CRYAB expression measurement","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — ChIP plus reporter assay, single lab","pmids":["27105535"],"is_preprint":false},{"year":2023,"finding":"HSPB5 interacts with SMAD4 and this interaction promotes SMAD4 canonical nuclear translocation in TGF-β1 signaling; chemical inhibitor NCI-41356 reduces HSPB5/SMAD4 interaction and blocks SMAD4 nuclear translocation, reducing pulmonary fibrosis markers in vitro and in vivo.","method":"Co-immunoprecipitation of HSPB5 with SMAD4, immunofluorescence for SMAD4 nuclear translocation, bleomycin mouse model with NCI-41356 treatment, collagen quantification","journal":"Pharmaceuticals (Basel, Switzerland)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP of interaction + functional inhibitor blocking nuclear translocation + in vivo rescue, single lab","pmids":["37259327"],"is_preprint":false},{"year":2016,"finding":"Phosphorylation of HspB5 at S45 and S59 (but not S19) is essential for its ability to increase dendritic complexity; non-phosphorylatable HspB5-AAA fails to protect dendrites, while phosphomimetic HspB5-AEE (S45E/S59E-like) recapitulates the wild-type effect both in vitro and in vivo (in utero electroporation).","method":"Overexpression of phospho-mutant and phosphomimetic HspB5 constructs in cultured hippocampal neurons and in vivo via in utero electroporation, Sholl analysis of dendritic morphology","journal":"Cellular and molecular life sciences : CMLS","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phosphosite mutagenesis with in vitro and in vivo dendritic morphology readout, single lab","pmids":["27085702"],"is_preprint":false},{"year":2011,"finding":"In vitro, HspB5 forms hetero-oligomeric complexes with HspB1 and HspB4; subunit exchange kinetics are faster between HspB5 and HspB1 than between HspB5 and HspB4; the resulting hetero-complexes have distinct structural organization, stability, and chaperone-like activities compared to homo-oligomers.","method":"Biochemical reconstitution, small-angle X-ray scattering (SAXS), subunit exchange kinetics assay, chaperone activity assays","journal":"Biochimie","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro reconstitution with biophysical characterization, single lab","pmids":["22210387"],"is_preprint":false},{"year":2019,"finding":"HSPB5 and HSPB1 interact with lipid membranes differently; the alpha-crystallin domain of HSPB5 is embedded within liposomes as identified by proteinase K protection followed by mass spectrometry, suggesting the alpha-crystallin domain mediates membrane interaction relevant to non-classical secretion.","method":"Liposome binding assay, proteinase K protection experiment, mass spectrometry of protected membrane-embedded domains","journal":"Cell stress & chaperones","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro reconstitution with liposomes plus MS domain mapping, single lab","pmids":["31338686"],"is_preprint":false},{"year":2020,"finding":"The 343delT HSPB5 mutant protein is extremely insoluble and does not accumulate to detectable levels in iPSC-derived skeletal myotubes and cardiomyocytes; co-expression of wild-type HSPB5 rescues 343delT solubility both in vitro and in cells through direct interaction, supporting a loss-of-function model for the recessive myopathy.","method":"iPSC-derived patient cells (homozygous and gene-corrected heterozygous), BHK21 cells lacking HSPB5, in vitro refolding assay, co-immunoprecipitation of WT and 343delT","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patient-derived iPSCs plus in vitro reconstitution, Co-IP interaction, single lab","pmids":["27226619"],"is_preprint":false},{"year":2022,"finding":"CRYAB (HSPB5) is identified as a senescence-induced survival gene; chemical inhibition of CRYAB by 25-hydroxycholesterol (25HC) induces senolysis in mouse and human senescent cells in culture and in vivo in mouse skeletal muscle.","method":"Single-cell RNA sequencing to identify CRYAB as senescence-induced gene, chemical inhibitor screening, validation in multiple cell types and in vivo mouse skeletal muscle","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — scRNA-seq target identification + in vitro/in vivo pharmacological validation, single lab","pmids":["35198901"],"is_preprint":false},{"year":2024,"finding":"LBH transcription factor upregulates CRYAB expression; the LBH-CRYAB signaling axis inhibits both mitochondrial apoptosis and ferroptosis in cardiomyocytes during I/R injury, with p53 identified as a mutual downstream effector for both death pathways.","method":"Pharmacological inhibitors, ectopic expression vectors, LBH/CRYAB knockout mouse models, apoptosis and ferroptosis assays in I/R injury model","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — knockout mouse models with defined pathway placement, single lab","pmids":["38660406"],"is_preprint":false},{"year":2020,"finding":"CRYAB suppresses the IKKβ-mediated canonical NF-κB pathway (but not the IKKα noncanonical path) in hepatic ischemia/reperfusion injury. CRYAB also activates M2 macrophage polarization through Akt1/mTOR signaling, alleviating liver IRI.","method":"Western blot and immunofluorescence for IKKβ/IKKα pathway components, Akt1/mTOR pathway analysis, miR-450b-5p inhibition to restore CRYAB, in vivo hepatic IRI mouse model","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway dissection with multiple readouts in cell and animal models, single lab","pmids":["32532961"],"is_preprint":false},{"year":2020,"finding":"A phosphomimetic form of HspB5 (but not wild-type or non-phosphorylatable forms) increases plasma membrane trafficking, function, and stability of F508del-CFTR, with effects further enhanced by CFTR corrector/potentiator drugs.","method":"Phosphomimetic and non-phosphorylatable HspB5 mutant expression in cell lines, CFTR surface biotinylation, electrophysiology (CFTR function), co-immunoprecipitation","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phospho-mutagenesis with functional CFTR assays, single lab","pmids":["32650630"],"is_preprint":false}],"current_model":"CRYAB (αB-crystallin/HSPB5) is an ATP-independent 'holdase' molecular chaperone that exists in reversible nonactivated and activated oligomeric states controlled by N-terminal region (NTR) accessibility and dimer-interface integrity; disease-associated mutations (R120G, D109H) or acidic pH constitutively expose the NTR to enable client binding, while wild-type HSPB5 uses pH-sensing at a conserved His-104 to toggle chaperone activity. Beyond protein quality control, CRYAB protects cytoskeletal integrity by interacting with actin crosslinkers (filamin/Cheerio) and F-actin, maintains cardiac mechanical function, inhibits caspase-mediated apoptosis and ferroptosis through interactions with cytochrome c/VDAC and stabilization of FTH1, modulates NF-κB signaling by inhibiting IKKβ, suppresses STAT3 activity via nuclear co-localization, stabilizes β-catenin against ubiquitin-proteasomal degradation to promote Wnt signaling, and facilitates degradation of client proteins (including p53 mutants) through interaction with the Fbx4 ubiquitin ligase. Phosphorylation at Ser45/Ser59 modulates its dendritic protective function, while phosphorylation at Ser59 inhibits its non-classical secretion via exosomes."},"narrative":{"mechanistic_narrative":"CRYAB (αB-crystallin/HSPB5) is an ATP-independent small heat-shock protein chaperone whose 'holdase' activity is gated by reversible transitions between low-activity nonactivated and high-activity activated oligomeric states, controlled by accessibility of the disordered N-terminal region and integrity of the α-crystallin domain (ACD) dimer interface [PMID:40377988]. A conserved histidine (His-104) in the ACD dimer interface senses acidosis: its destabilization or mutation shifts the ACD from dimer toward monomer, expands oligomers, and produces constitutively activated holdase complexes [PMID:25962097], while disease mutants R120G and D109H mimic this constitutive NTR exposure and raise coaggregation propensity [PMID:40377988]. CRYAB delays client aggregation through transient early-pathway interactions in the nonactivated state and engages later aggregation stages once activated [PMID:30567736], and it suppresses aggregation of clients including α-synuclein [PMID:28337642] and itself forms hetero-oligomers with HSPB1/HSPB4 via subunit exchange to modulate activity [PMID:22210387]. Aggregation-prone CRYAB mutants (R120G, frameshift variants) form toxic amyloid oligomers that are countered by other small HSPs through competitive hetero-oligomer incorporation and ubiquitin-proteasomal clearance [PMID:17092938, PMID:20863832, PMID:25961584]. Beyond protein quality control, CRYAB preserves cytoskeletal and sarcomeric integrity through a conserved actin-binding domain and physical interaction with the filamin/Cheerio actin crosslinker [PMID:25715399], translocates to the nucleus under heat stress to reduce F-actin aggregation and caspase-3 apoptosis [PMID:30246229], and protects cardiac contractile/diastolic mechanical function [PMID:17846079]. It acts as an antiapoptotic mitochondrial chaperone by interacting with cytochrome c and VDAC to support OXPHOS assembly [PMID:39561005] and limits ferroptosis by stabilizing ferritin heavy chain FTH1 against proteasomal degradation [PMID:38787373]. CRYAB modulates multiple signaling pathways: it stabilizes β-catenin against ubiquitination to promote canonical Wnt signaling [PMID:22158051, PMID:31638302], inhibits IKKβ-mediated canonical NF-κB signaling [PMID:31481750, PMID:32532961], suppresses STAT3 DNA-binding activity upon nuclear translocation [PMID:27724964], promotes SMAD4 nuclear translocation in TGF-β1 signaling [PMID:37259327], and supports degradation of mutant p53 via the Fbx4 ubiquitin ligase under HSF1 control [PMID:19343786]. Phosphorylation at Ser45/Ser59 is required for its dendrite-protective function [PMID:27085702], while phosphorylation negatively regulates its O-GlcNAcylation-dependent non-classical secretion via exosomes [PMID:26620801]. Recessive loss-of-function (343delT) causes myopathy through protein insolubility rescuable by wild-type co-expression [PMID:27226619], and CRYAB function is therapeutically targetable by stereoselective small-molecule binding to its dimer to reverse cataract [PMID:31369034].","teleology":[{"year":2007,"claim":"Established that CRYAB protects the specifically mechanical (contractile/diastolic) properties of the heart, distinguishing its in vivo physiological role from energetic protection by HSPB2.","evidence":"Genetic mouse models (DKO, mCryAB transgenic) with ischemia/reperfusion, 31P NMR cardiac energetics, contractile measurement","pmids":["17846079"],"confidence":"High","gaps":["Molecular basis linking chaperone activity to mechanical protection not defined","Does not identify the cardiac client proteins involved"]},{"year":2009,"claim":"Showed CRYAB acts as a degradation cofactor by linking mutant p53 to the Fbx4 ubiquitin ligase, connecting chaperone function to targeted proteolysis under HSF1 control.","evidence":"Reciprocal Co-IP of p53R175H with CRYAB and Fbx4, hsf1-/- and alphaBcry-/- MEFs, ectopic Fbx4 stability assays","pmids":["19343786"],"confidence":"Medium","gaps":["Whether CRYAB is a general adaptor for Fbx4 substrates unknown","Structural basis of the p53-CRYAB-Fbx4 ternary interaction not resolved"]},{"year":2006,"claim":"Defined that the disease mutant R120G forms toxic amyloid oligomers and that other small HSPs can interrupt this to restore proteostasis and viability.","evidence":"Recombinant protein assays, native PAGE, anti-oligomer antibody, adenoviral cardiomyocyte expression, proteasome activity assay","pmids":["17092938"],"confidence":"High","gaps":["Atomic structure of the toxic oligomer not determined","How HSP22/HSP25 physically block oligomerization unresolved"]},{"year":2010,"claim":"Demonstrated that aggregate-prone CRYAB mutants are cleared by the ubiquitin-proteasome system, with HSPB1 directing this degradation.","evidence":"Co-expression in H9c2 cells, HSPB1 overexpression/knockdown, proteasome inhibitor, ubiquitin conjugate immunoblot","pmids":["20863832"],"confidence":"High","gaps":["E3 ligase mediating mutant ubiquitination not identified","Selectivity for mutant over wild-type not mechanistically explained"]},{"year":2011,"claim":"Mapped CRYAB engagement of adherens junctions, showing its core domain binds E-cadherin and β-catenin to retain β-catenin at the membrane and suppress Wnt target genes.","evidence":"Reciprocal Co-IP of endogenous E-cadherin/β-catenin with CRYAB, domain mapping, NPC xenograft assay","pmids":["22158051"],"confidence":"Medium","gaps":["Reconciliation with later report that CRYAB promotes Wnt signaling not addressed","Direct vs indirect nature of the β-catenin interaction not fully separated"]},{"year":2011,"claim":"Showed CRYAB forms hetero-oligomers with HSPB1 and HSPB4 with distinct exchange kinetics and chaperone activities, establishing oligomeric plasticity as a regulatory feature.","evidence":"Biochemical reconstitution, SAXS, subunit exchange kinetics, chaperone activity assays","pmids":["22210387"],"confidence":"Medium","gaps":["In vivo stoichiometry of hetero-oligomers unknown","Functional consequences in tissue not tested"]},{"year":2013,"claim":"Revealed a context-dependent role in NF-κB signaling, where CRYAB enhances TNF-α-induced NF-κB and adhesion molecule expression in endothelium.","evidence":"Ectopic expression and αB-crystallin-deficient endothelial cells, IκB measurement, in vivo leukocyte rolling","pmids":["23929007"],"confidence":"Medium","gaps":["Opposite (inhibitory) effect on NF-κB in epithelial contexts not reconciled","Direct molecular target in the NF-κB cascade not identified here"]},{"year":2007,"claim":"Identified transcriptional control of CRYAB by BRG1/SWI-SNF acting through a nucleosome-positioned response element requiring HMGA1.","evidence":"Promoter deletion, ChIP for HMGA1 in vivo, in vitro binding, luciferase reporter","pmids":["17723105"],"confidence":"Medium","gaps":["Physiological stimuli driving this regulation not defined","Tissue specificity of the element unclear"]},{"year":2015,"claim":"Defined His-104 in the ACD dimer interface as a pH sensor that toggles oligomer state and holdase activity, providing a structural basis for stress-activation.","evidence":"In vitro biochemistry, mutagenesis, dimer-interface structural analysis, pH-range chaperone assays","pmids":["25962097"],"confidence":"High","gaps":["In-cell relevance of His-104 pH sensing not demonstrated","Identity of physiological clients of the activated state not mapped"]},{"year":2015,"claim":"Established the conserved actin/sarcomere role: CryAB localizes to Z-bands and binds the filamin orthologue Cheerio, and R120G disrupts myofibrillar integrity in vivo.","evidence":"Mass spectrometry, Co-IP, muscle RNAi, transgenic R120G expression, sarcomere imaging, cardiac phenotyping in Drosophila","pmids":["25715399"],"confidence":"High","gaps":["Direct F-actin vs filamin contribution not fully separated","Whether human CRYAB binds filamin in muscle not directly tested"]},{"year":2015,"claim":"Showed phosphorylation negatively regulates non-classical exosomal secretion of CryAB, with O-GlcNAcylation required for packaging.","evidence":"YFP phosphomimetic constructs, CD63/Rab27 colocalization, exosome isolation and immunoblot","pmids":["26620801"],"confidence":"Medium","gaps":["Kinase responsible in this context not identified","Functional role of secreted CryAB not addressed"]},{"year":2016,"claim":"Demonstrated that Ser45/Ser59 phosphorylation is specifically required for CRYAB-mediated enhancement of dendritic complexity.","evidence":"Phospho-mutant/phosphomimetic constructs in hippocampal neurons and in utero electroporation, Sholl analysis","pmids":["27085702"],"confidence":"Medium","gaps":["Mechanism linking phosphorylation to dendrite morphology unknown","Relevant client/cytoskeletal effectors not identified"]},{"year":2016,"claim":"Placed CRYAB in anti-inflammatory signaling as a STAT3 partner that translocates to the nucleus and blocks STAT3 DNA binding.","evidence":"Co-IP with STAT3, EMSA, immunofluorescence, siRNA of DRD2/CRYAB in astrocytes","pmids":["27724964"],"confidence":"Medium","gaps":["Direct vs scaffold-mediated inhibition of STAT3 unresolved","How nuclear translocation is triggered not defined"]},{"year":2016,"claim":"Identified KLF4 as a direct transcriptional activator of CRYAB driving osteosarcoma proliferation and migration.","evidence":"ChIP at CRYAB promoter, luciferase reporter, KLF4 gain/loss with CRYAB readout","pmids":["27105535"],"confidence":"Medium","gaps":["Downstream CRYAB effectors in tumor cells not mapped","Generality across cancers untested"]},{"year":2016,"claim":"Supported a recessive loss-of-function disease model by showing the 343delT mutant is insoluble and rescued in solubility by direct interaction with wild-type CRYAB.","evidence":"Patient iPSC-derived myotubes/cardiomyocytes, HSPB5-null BHK21 cells, in vitro refolding, Co-IP","pmids":["27226619"],"confidence":"Medium","gaps":["Native fold/structure of 343delT not characterized","Tissue-specific thresholds for pathology unclear"]},{"year":2017,"claim":"Confirmed CRYAB suppresses intracellular aggregation of α-synuclein, extending its anti-aggregation chaperone activity to a neurodegeneration-relevant client.","evidence":"Bicistronic constructs in Neuro-2a cells, quantification of α-syn inclusions","pmids":["28337642"],"confidence":"Medium","gaps":["Whether interaction is direct and stoichiometric not shown","In vivo neuronal relevance not tested"]},{"year":2018,"claim":"Resolved state-dependent chaperone mechanism: nonactivated WT acts only early in aggregation, while activated mutant forms can also intervene at late stages.","evidence":"In vitro chaperone assays with α-lactalbumin, WT vs stress-mimicking mutants","pmids":["30567736"],"confidence":"Medium","gaps":["Single defined client limits generalization","Structural snapshots of late-stage engagement absent"]},{"year":2018,"claim":"Linked nuclear translocation under heat stress to cytoskeletal protection and apoptosis suppression in cardiomyocytes.","evidence":"Stable CRYAB-overexpressing H9C2 cells, immunofluorescence of CRYAB/F-actin, cleaved caspase-3, flow cytometry","pmids":["30246229"],"confidence":"Medium","gaps":["Nuclear import mechanism unknown","Direct vs indirect effect on caspase-3 unresolved"]},{"year":2019,"claim":"Reframed the CRYAB-β-catenin interaction as protective, stabilizing β-catenin against ubiquitination to promote Wnt-driven osteogenesis.","evidence":"Co-IP, in vitro ubiquitination, Wnt luciferase reporter, gain/loss in BMSCs, in vivo bone formation","pmids":["31638302"],"confidence":"Medium","gaps":["Contradiction with adherens-junction sequestration model not reconciled","Mechanism by which CRYAB blocks β-catenin ubiquitination undefined"]},{"year":2019,"claim":"Defined CRYAB inhibition of canonical NF-κB by blocking IKK complex formation, with anti-inflammatory protection in colitis models.","evidence":"Lentiviral overexpression and CRISPR knockout, IKK complex immunoblot, cytokine assays, TAT-CRYAB in DSS/TNBS colitis","pmids":["31481750"],"confidence":"Medium","gaps":["Direct CRYAB-IKKβ binding not structurally shown","Reconciliation with endothelial pro-NF-κB role missing"]},{"year":2019,"claim":"Showed the ACD mediates direct membrane interaction by embedding within liposomes, a feature relevant to non-classical secretion.","evidence":"Liposome binding, proteinase K protection, MS of protected domains","pmids":["31338686"],"confidence":"Medium","gaps":["Membrane topology in cells not confirmed","Link to a specific secretion route not established"]},{"year":2019,"claim":"Established CRYAB dimers as a druggable target, with stereoselective oxysterol binding required to reverse lens opacity.","evidence":"In silico docking, DSF, MST, topical treatment of R120G and aged cataract mice, TEM","pmids":["31369034"],"confidence":"High","gaps":["Co-structure of CRYAB-ligand complex not solved","Whether binding reactivates physiological chaperone function unclear"]},{"year":2020,"claim":"Extended NF-κB suppression to hepatic I/R injury and added Akt1/mTOR-driven M2 macrophage polarization as a parallel protective mechanism.","evidence":"IKKβ/IKKα pathway immunoblot/IF, Akt1/mTOR analysis, miR-450b-5p inhibition, in vivo hepatic IRI","pmids":["32532961"],"confidence":"Medium","gaps":["Whether macrophage effect is cell-autonomous or secreted-CRYAB mediated unclear","Direct IKKβ engagement not shown structurally"]},{"year":2020,"claim":"Showed phosphomimetic HspB5 enhances plasma membrane trafficking and stability of F508del-CFTR, indicating phosphorylation-state-dependent client handling.","evidence":"Phospho-mutant expression, CFTR surface biotinylation, electrophysiology, Co-IP","pmids":["32650630"],"confidence":"Medium","gaps":["Direct CRYAB-CFTR binding interface undefined","In vivo relevance to cystic fibrosis untested"]},{"year":2022,"claim":"Identified CRYAB as a senescence-induced survival gene whose chemical inhibition triggers senolysis.","evidence":"Single-cell RNA-seq, chemical inhibitor (25HC), in vitro/in vivo skeletal muscle validation","pmids":["35198901"],"confidence":"Medium","gaps":["Molecular survival pathway protected by CRYAB in senescent cells not defined","Selectivity of 25HC for CRYAB incomplete"]},{"year":2023,"claim":"Connected HSPB5 to TGF-β1 signaling by promoting SMAD4 nuclear translocation, with druggable disruption reducing fibrosis.","evidence":"Co-IP with SMAD4, SMAD4 nuclear IF, NCI-41356 inhibitor, bleomycin mouse model, collagen quantification","pmids":["37259327"],"confidence":"Medium","gaps":["Whether interaction is direct unconfirmed","Mechanism of SMAD4 import facilitation unknown"]},{"year":2023,"claim":"Identified NUAK kinase as an upstream regulator phosphorylating conserved serines on CryAB to prevent its aggregation in muscle.","evidence":"CRISPR kinase-dead mutation, yeast 2-hybrid, phospho-mimetic NUAK, phosphosite mutagenesis, Drosophila muscle phenotype","pmids":["37713608"],"confidence":"Medium","gaps":["Direct in vitro phosphorylation by NUAK not shown","Whether human NUAK phosphorylates human CRYAB at these sites untested"]},{"year":2024,"claim":"Defined CRYAB as a mitochondrial antiapoptotic chaperone binding cytochrome c and VDAC to support OXPHOS, with a disease mutation impairing these interactions.","evidence":"Co-IP of WT and p.E105K with cytochrome c/VDAC, OXPHOS activity assays, Cryab knock-in/knockout mouse retinal phenotyping","pmids":["39561005"],"confidence":"Medium","gaps":["Whether CRYAB resides inside mitochondria or at the outer membrane unresolved","Stoichiometry of cytochrome c/VDAC binding undefined"]},{"year":2024,"claim":"Showed CRYAB stabilizes ferritin heavy chain FTH1 against proteasomal degradation in a lactylation-dependent manner to suppress ferroptosis.","evidence":"IP-MS, Co-IP of CRYAB-FTH1, knockdown with Fe/ROS and ferroptosis assays in BMSCs","pmids":["38787373"],"confidence":"Medium","gaps":["How lactylation controls the interaction mechanistically unclear","Whether CRYAB directly blocks FTH1 ubiquitination untested"]},{"year":2024,"claim":"Placed CRYAB in a LBH-CRYAB axis that inhibits both apoptosis and ferroptosis through a shared p53 effector in cardiac I/R injury.","evidence":"Inhibitors, ectopic expression, LBH/CRYAB knockout mice, apoptosis and ferroptosis assays","pmids":["38660406"],"confidence":"Medium","gaps":["Direct CRYAB-p53 regulation in this context not mapped","Mechanism converging two death pathways on p53 unresolved"]},{"year":null,"claim":"How CRYAB's reversible oligomeric activation state is selectively coupled to its many divergent and sometimes opposite client and signaling functions in vivo remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking activation state to specific client/pathway selection","Opposing NF-κB and Wnt effects across tissues not mechanistically reconciled","Atomic structures of client-bound activated complexes lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[0,1,2,18,27]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[3,9,8,20]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[14,17]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[10,11,23]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[6,7,8]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[13,17]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[10,17]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[14,17]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[20]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[7,26,31]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[3,4,6,9]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[17,20,29]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8,10,11,23,30]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[0,1,17]},{"term_id":"R-HSA-397014","term_label":"Muscle contraction","supporting_discovery_ids":[14,16]}],"complexes":[],"partners":["FTH1","VDAC","CYCS","CTNNB1","STAT3","SMAD4","FLNA","HSPB1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P02511","full_name":"Alpha-crystallin B chain","aliases":["Alpha(B)-crystallin","Heat shock protein beta-5","HspB5","Heat shock protein family B member 5","Renal carcinoma antigen NY-REN-27","Rosenthal fiber component"],"length_aa":175,"mass_kda":20.2,"function":"May contribute to the transparency and refractive index of the lens. Has chaperone-like activity, preventing aggregation of various proteins under a wide range of stress conditions. In lens epithelial cells, stabilizes the ATP6V1A protein, preventing its degradation by the proteasome (By similarity)","subcellular_location":"Cytoplasm; Nucleus; Secreted; Lysosome","url":"https://www.uniprot.org/uniprotkb/P02511/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CRYAB","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CRYAB","total_profiled":1310},"omim":[{"mim_id":"621529","title":"TRANSMEMBRANE PROTEIN 168; TMEM168","url":"https://www.omim.org/entry/621529"},{"mim_id":"620775","title":"NEUROMUSCULAR DISORDER, CONGENITAL, WITH DYSMORPHIC FACIES; NMDF","url":"https://www.omim.org/entry/620775"},{"mim_id":"619168","title":"TRANSMEMBRANE PROTEIN 109; TMEM109","url":"https://www.omim.org/entry/619168"},{"mim_id":"615184","title":"CARDIOMYOPATHY, DILATED, 1II; CMD1II","url":"https://www.omim.org/entry/615184"},{"mim_id":"613869","title":"MYOPATHY, MYOFIBRILLAR, 2B, INFANTILE-ONSET; MFM2B","url":"https://www.omim.org/entry/613869"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Plasma membrane","reliability":"Enhanced"},{"location":"Cytosol","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"heart muscle","ntpm":10537.6},{"tissue":"skeletal muscle","ntpm":7429.7},{"tissue":"tongue","ntpm":8772.8}],"url":"https://www.proteinatlas.org/search/CRYAB"},"hgnc":{"alias_symbol":["HSPB5"],"prev_symbol":["CRYA2"]},"alphafold":{"accession":"P02511","domains":[{"cath_id":"2.60.40.790","chopping":"65-147","consensus_level":"high","plddt":92.5639,"start":65,"end":147}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P02511","model_url":"https://alphafold.ebi.ac.uk/files/AF-P02511-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P02511-F1-predicted_aligned_error_v6.png","plddt_mean":75.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CRYAB","jax_strain_url":"https://www.jax.org/strain/search?query=CRYAB"},"sequence":{"accession":"P02511","fasta_url":"https://rest.uniprot.org/uniprotkb/P02511.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P02511/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P02511"}},"corpus_meta":[{"pmid":"17467701","id":"PMC_17467701","title":"Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17467701","citation_count":258,"is_preprint":false},{"pmid":"22521623","id":"PMC_22521623","title":"Small heat shock proteins HSP27 (HspB1), αB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death.","date":"2012","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22521623","citation_count":231,"is_preprint":false},{"pmid":"11577372","id":"PMC_11577372","title":"Alpha-B crystallin gene (CRYAB) mutation causes dominant congenital posterior polar cataract in humans.","date":"2001","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11577372","citation_count":205,"is_preprint":false},{"pmid":"31097690","id":"PMC_31097690","title":"M2 macrophages promote NSCLC metastasis by upregulating CRYAB.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31097690","citation_count":113,"is_preprint":false},{"pmid":"32532961","id":"PMC_32532961","title":"Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32532961","citation_count":103,"is_preprint":false},{"pmid":"27724964","id":"PMC_27724964","title":"Sinomenine activates astrocytic dopamine D2 receptors and alleviates neuroinflammatory injury via the CRYAB/STAT3 pathway after ischemic stroke in mice.","date":"2016","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/27724964","citation_count":86,"is_preprint":false},{"pmid":"21920752","id":"PMC_21920752","title":"A novel CRYAB mutation resulting in multisystemic disease.","date":"2011","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/21920752","citation_count":85,"is_preprint":false},{"pmid":"25261722","id":"PMC_25261722","title":"Inflammatory cytokines, interleukin-1 beta and tumor necrosis factor-alpha, upregulated in glioblastoma multiforme, raise the levels of CRYAB in exosomes secreted by U373 glioma cells.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25261722","citation_count":83,"is_preprint":false},{"pmid":"17761354","id":"PMC_17761354","title":"Aging skeletal muscle shows a drastic increase in the small heat shock proteins alphaB-crystallin/HspB5 and cvHsp/HspB7.","date":"2007","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17761354","citation_count":78,"is_preprint":false},{"pmid":"24514166","id":"PMC_24514166","title":"HspB1, HspB5 and HspB4 in Human Cancers: Potent Oncogenic Role of Some of Their Client Proteins.","date":"2014","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/24514166","citation_count":77,"is_preprint":false},{"pmid":"31239701","id":"PMC_31239701","title":"Progression of the role of CRYAB in signaling pathways and cancers.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31239701","citation_count":73,"is_preprint":false},{"pmid":"20171888","id":"PMC_20171888","title":"The p.G154S mutation of the alpha-B crystallin gene (CRYAB) causes late-onset distal myopathy.","date":"2010","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/20171888","citation_count":70,"is_preprint":false},{"pmid":"28493373","id":"PMC_28493373","title":"The novel αB-crystallin (CRYAB) mutation p.D109G causes restrictive cardiomyopathy.","date":"2017","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/28493373","citation_count":61,"is_preprint":false},{"pmid":"25962097","id":"PMC_25962097","title":"A conserved histidine modulates HSPB5 structure to trigger chaperone activity in response to stress-related acidosis.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/25962097","citation_count":59,"is_preprint":false},{"pmid":"17092938","id":"PMC_17092938","title":"Interruption of CryAB-amyloid oligomer formation by HSP22.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17092938","citation_count":58,"is_preprint":false},{"pmid":"34800628","id":"PMC_34800628","title":"Salvianolic acid A relieves cognitive disorder after chronic cerebral ischemia: Involvement of Drd2/Cryab/NF-κB pathway.","date":"2021","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/34800628","citation_count":57,"is_preprint":false},{"pmid":"30425783","id":"PMC_30425783","title":"Rosemary Reduces Heat Stress by Inducing CRYAB and HSP70 Expression in Broiler Chickens.","date":"2018","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/30425783","citation_count":55,"is_preprint":false},{"pmid":"22158051","id":"PMC_22158051","title":"Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22158051","citation_count":55,"is_preprint":false},{"pmid":"23697380","id":"PMC_23697380","title":"Protein interactomes of three stress inducible small heat shock proteins: HspB1, HspB5 and HspB8.","date":"2013","source":"International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group","url":"https://pubmed.ncbi.nlm.nih.gov/23697380","citation_count":52,"is_preprint":false},{"pmid":"29425965","id":"PMC_29425965","title":"The small heat shock proteins, especially HspB4 and HspB5 are promising protectants in neurodegenerative diseases.","date":"2018","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/29425965","citation_count":52,"is_preprint":false},{"pmid":"16877416","id":"PMC_16877416","title":"Identification of a CRYAB mutation associated with autosomal dominant posterior polar cataract in a Chinese family.","date":"2006","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/16877416","citation_count":52,"is_preprint":false},{"pmid":"27904835","id":"PMC_27904835","title":"A novel dominant D109A CRYAB mutation in a family with myofibrillar myopathy affects αB-crystallin structure.","date":"2016","source":"BBA clinical","url":"https://pubmed.ncbi.nlm.nih.gov/27904835","citation_count":48,"is_preprint":false},{"pmid":"20863832","id":"PMC_20863832","title":"Selective degradation of aggregate-prone CryAB mutants by HSPB1 is mediated by ubiquitin-proteasome pathways.","date":"2010","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/20863832","citation_count":47,"is_preprint":false},{"pmid":"28337642","id":"PMC_28337642","title":"The small heat shock proteins αB-crystallin (HSPB5) and Hsp27 (HSPB1) inhibit the intracellular aggregation of α-synuclein.","date":"2017","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/28337642","citation_count":46,"is_preprint":false},{"pmid":"25715399","id":"PMC_25715399","title":"Drosophila small heat shock protein CryAB ensures structural integrity of developing muscles, and proper muscle and heart performance.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25715399","citation_count":45,"is_preprint":false},{"pmid":"31481750","id":"PMC_31481750","title":"Small heat shock protein CRYAB inhibits intestinal mucosal inflammatory responses and protects barrier integrity through suppressing IKKβ activity.","date":"2019","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31481750","citation_count":44,"is_preprint":false},{"pmid":"33144585","id":"PMC_33144585","title":"MiRNA-671-5p Promotes prostate cancer development and metastasis by targeting NFIA/CRYAB axis.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33144585","citation_count":43,"is_preprint":false},{"pmid":"21130652","id":"PMC_21130652","title":"Infantile onset myofibrillar myopathy due to recessive CRYAB mutations.","date":"2010","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/21130652","citation_count":40,"is_preprint":false},{"pmid":"29867551","id":"PMC_29867551","title":"BYD Ameliorates Oxidative Stress-Induced Myocardial Apoptosis in Heart Failure Post-Acute Myocardial Infarction via the P38 MAPK-CRYAB Signaling Pathway.","date":"2018","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29867551","citation_count":39,"is_preprint":false},{"pmid":"19461931","id":"PMC_19461931","title":"Identification of a novel CRYAB mutation associated with autosomal recessive juvenile cataract in a Saudi family.","date":"2009","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/19461931","citation_count":39,"is_preprint":false},{"pmid":"35198901","id":"PMC_35198901","title":"Senolysis induced by 25-hydroxycholesterol targets CRYAB in multiple cell types.","date":"2022","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/35198901","citation_count":38,"is_preprint":false},{"pmid":"17873008","id":"PMC_17873008","title":"CRYAB and HSPB2 deficiency alters cardiac metabolism and paradoxically confers protection against myocardial ischemia in aging mice.","date":"2007","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17873008","citation_count":38,"is_preprint":false},{"pmid":"33761953","id":"PMC_33761953","title":"Presence and activation of pro-inflammatory macrophages are associated with CRYAB expression in vitro and after peripheral nerve injury.","date":"2021","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/33761953","citation_count":37,"is_preprint":false},{"pmid":"19597569","id":"PMC_19597569","title":"A novel mutation in CRYAB associated with autosomal dominant congenital nuclear cataract in a Chinese family.","date":"2009","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/19597569","citation_count":36,"is_preprint":false},{"pmid":"26620801","id":"PMC_26620801","title":"Phosphorylation negatively regulates exosome mediated secretion of cryAB in glioma cells.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/26620801","citation_count":34,"is_preprint":false},{"pmid":"30246229","id":"PMC_30246229","title":"CRYAB protects cardiomyocytes against heat stress by preventing caspase-mediated apoptosis and reducing F-actin aggregation.","date":"2018","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/30246229","citation_count":32,"is_preprint":false},{"pmid":"26402864","id":"PMC_26402864","title":"Missense Mutations in CRYAB Are Liable for Recessive Congenital Cataracts.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26402864","citation_count":32,"is_preprint":false},{"pmid":"17846079","id":"PMC_17846079","title":"Unmasking different mechanical and energetic roles for the small heat shock proteins CryAB and HSPB2 using genetically modified mouse hearts.","date":"2007","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/17846079","citation_count":31,"is_preprint":false},{"pmid":"38787373","id":"PMC_38787373","title":"CRYAB suppresses ferroptosis and promotes osteogenic differentiation of human bone marrow stem cells via binding and stabilizing FTH1.","date":"2024","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/38787373","citation_count":30,"is_preprint":false},{"pmid":"19343786","id":"PMC_19343786","title":"Heat shock factor 1 deficiency via its downstream target gene alphaB-crystallin (Hspb5) impairs p53 degradation.","date":"2009","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19343786","citation_count":30,"is_preprint":false},{"pmid":"33659004","id":"PMC_33659004","title":"Novel Secreted Protein of Mycoplasma bovis MbovP280 Induces Macrophage Apoptosis Through CRYAB.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33659004","citation_count":29,"is_preprint":false},{"pmid":"16184762","id":"PMC_16184762","title":"Differential expression of alphaB-crystallin and Hsp27-1 in anaplastic thyroid carcinomas because of tumor-specific alphaB-crystallin gene (CRYAB) silencing.","date":"2005","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/16184762","citation_count":29,"is_preprint":false},{"pmid":"31945401","id":"PMC_31945401","title":"Qishen Granule alleviates endoplasmic reticulum stress-induced myocardial apoptosis through IRE-1-CRYAB pathway in myocardial ischemia.","date":"2020","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31945401","citation_count":29,"is_preprint":false},{"pmid":"31638302","id":"PMC_31638302","title":"CRYAB promotes osteogenic differentiation of human bone marrow stem cells via stabilizing β-catenin and promoting the Wnt signalling.","date":"2019","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/31638302","citation_count":29,"is_preprint":false},{"pmid":"31829429","id":"PMC_31829429","title":"CRYAB inhibits migration and invasion of bladder cancer cells through the PI3K/AKT and ERK pathways.","date":"2020","source":"Japanese journal of clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31829429","citation_count":28,"is_preprint":false},{"pmid":"22210387","id":"PMC_22210387","title":"Structural and functional specificity of small heat shock protein HspB1 and HspB4, two cellular partners of HspB5: role of the in vitro hetero-complex formation in chaperone activity.","date":"2011","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/22210387","citation_count":28,"is_preprint":false},{"pmid":"27105535","id":"PMC_27105535","title":"Krüppel-like factor 4 promotes human osteosarcoma growth and metastasis via regulating CRYAB expression.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27105535","citation_count":27,"is_preprint":false},{"pmid":"28425051","id":"PMC_28425051","title":"Upregulation and phosphorylation of HspB1/Hsp25 and HspB5/αB-crystallin after transient middle cerebral artery occlusion in rats.","date":"2017","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/28425051","citation_count":27,"is_preprint":false},{"pmid":"31369034","id":"PMC_31369034","title":"Mechanism of Action of VP1-001 in cryAB(R120G)-Associated and Age-Related Cataracts.","date":"2019","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/31369034","citation_count":26,"is_preprint":false},{"pmid":"21541347","id":"PMC_21541347","title":"Cardioprotective effect of nicorandil, a mitochondrial ATP-sensitive potassium channel opener, prolongs survival in HSPB5 R120G transgenic mice.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21541347","citation_count":26,"is_preprint":false},{"pmid":"30036999","id":"PMC_30036999","title":"The Role of the Arginine in the Conserved N-Terminal Domain RLFDQxFG Motif of Human Small Heat Shock Proteins HspB1, HspB4, HspB5, HspB6, and HspB8.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30036999","citation_count":25,"is_preprint":false},{"pmid":"23950959","id":"PMC_23950959","title":"Analysis of the dominant effects mediated by wild type or R120G mutant of αB-crystallin (HspB5) towards Hsp27 (HspB1).","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23950959","citation_count":24,"is_preprint":false},{"pmid":"2370055","id":"PMC_2370055","title":"Human alpha B-crystallin (CRYA2) gene mapped to chromosome 11q12-q23.","date":"1990","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2370055","citation_count":23,"is_preprint":false},{"pmid":"31338686","id":"PMC_31338686","title":"The small heat shock proteins, HSPB1 and HSPB5, interact differently with lipid membranes.","date":"2019","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/31338686","citation_count":23,"is_preprint":false},{"pmid":"23929007","id":"PMC_23929007","title":"αB-crystallin/HspB5 regulates endothelial-leukocyte interactions by enhancing NF-κB-induced up-regulation of adhesion molecules ICAM-1, VCAM-1 and E-selectin.","date":"2013","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/23929007","citation_count":21,"is_preprint":false},{"pmid":"36773525","id":"PMC_36773525","title":"Salvianolic acid A improve mitochondrial respiration and cardiac function via inhibiting apoptosis pathway through CRYAB in diabetic cardiomyopathy.","date":"2023","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/36773525","citation_count":21,"is_preprint":false},{"pmid":"33032360","id":"PMC_33032360","title":"Mog1 knockout causes cardiac hypertrophy and heart failure by downregulating tbx5-cryab-hspb2 signalling in zebrafish.","date":"2020","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/33032360","citation_count":20,"is_preprint":false},{"pmid":"20141356","id":"PMC_20141356","title":"Later retinal degeneration following childhood surgical aphakia in a family with recessive CRYAB mutation (p.R56W).","date":"2010","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20141356","citation_count":20,"is_preprint":false},{"pmid":"17723105","id":"PMC_17723105","title":"HMGA1 mediates the activation of the CRYAB promoter by BRG1.","date":"2007","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17723105","citation_count":19,"is_preprint":false},{"pmid":"27085702","id":"PMC_27085702","title":"HspB5/αB-crystallin increases dendritic complexity and protects the dendritic arbor during heat shock in cultured rat hippocampal neurons.","date":"2016","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/27085702","citation_count":19,"is_preprint":false},{"pmid":"19878675","id":"PMC_19878675","title":"Changes in retinal alphaB-crystallin (cryab) RNA transcript levels during periods of altered ocular growth in chickens.","date":"2009","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/19878675","citation_count":18,"is_preprint":false},{"pmid":"32420686","id":"PMC_32420686","title":"A novel dominant mutation in CRYAB gene leading to a severe phenotype with childhood onset.","date":"2020","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32420686","citation_count":16,"is_preprint":false},{"pmid":"35302657","id":"PMC_35302657","title":"In high-grade ovarian carcinoma, platinum-sensitive tumor recurrence and acquired-resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and SOX2.","date":"2022","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/35302657","citation_count":15,"is_preprint":false},{"pmid":"27226619","id":"PMC_27226619","title":"The Human 343delT HSPB5 Chaperone Associated with Early-onset Skeletal Myopathy Causes Defects in Protein Solubility.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27226619","citation_count":15,"is_preprint":false},{"pmid":"25961584","id":"PMC_25961584","title":"Rescue of αB Crystallin (HSPB5) Mutants Associated Protein Aggregation by Co-Expression of HSPB5 Partners.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25961584","citation_count":14,"is_preprint":false},{"pmid":"36086960","id":"PMC_36086960","title":"CRYAB reduces cigarette smoke-induced inflammation, apoptosis, and oxidative stress by retarding PI3K/Akt and NF-κB signaling pathways in human bronchial epithelial cells.","date":"2022","source":"Allergologia et immunopathologia","url":"https://pubmed.ncbi.nlm.nih.gov/36086960","citation_count":14,"is_preprint":false},{"pmid":"30463298","id":"PMC_30463298","title":"Sub-Toxic Human Amylin Fragment Concentrations Promote the Survival and Proliferation of SH-SY5Y Cells via the Release of VEGF and HspB5 from Endothelial RBE4 Cells.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30463298","citation_count":14,"is_preprint":false},{"pmid":"32668633","id":"PMC_32668633","title":"Chaperone-Like Activity of HSPB5: The Effects of Quaternary Structure Dynamics and Crowding.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32668633","citation_count":14,"is_preprint":false},{"pmid":"21980040","id":"PMC_21980040","title":"Association of Alpha B-Crystallin (CRYAB) genotypes with breast cancer susceptibility in Taiwan.","date":"2011","source":"Cancer genomics & proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/21980040","citation_count":14,"is_preprint":false},{"pmid":"30567736","id":"PMC_30567736","title":"HSPB5 engages multiple states of a destabilized client to enhance chaperone activity in a stress-dependent manner.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30567736","citation_count":14,"is_preprint":false},{"pmid":"39742283","id":"PMC_39742283","title":"In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis.","date":"2024","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39742283","citation_count":13,"is_preprint":false},{"pmid":"36121023","id":"PMC_36121023","title":"Novel mycoplasma nucleomodulin MbovP475 decreased cell viability by regulating expression of CRYAB and MCF2L2.","date":"2022","source":"Virulence","url":"https://pubmed.ncbi.nlm.nih.gov/36121023","citation_count":13,"is_preprint":false},{"pmid":"32595446","id":"PMC_32595446","title":"HspB5 Activates a Neuroprotective Glial Cell Response in Experimental Tauopathy.","date":"2020","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32595446","citation_count":13,"is_preprint":false},{"pmid":"23579188","id":"PMC_23579188","title":"Differential expression and regulation of Cryab in mouse uterus during preimplantation period.","date":"2013","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23579188","citation_count":13,"is_preprint":false},{"pmid":"20804537","id":"PMC_20804537","title":"αB-crystallin (HspB5) in familial amyloidotic polyneuropathy.","date":"2010","source":"International journal of experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20804537","citation_count":13,"is_preprint":false},{"pmid":"33925547","id":"PMC_33925547","title":"Identification of CRYAB+ KCNN3+ SOX9+ Astrocyte-Like and EGFR+ PDGFRA+ OLIG1+ Oligodendrocyte-Like Tumoral Cells in Diffuse IDH1-Mutant Gliomas and Implication of NOTCH1 Signalling in Their Genesis.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33925547","citation_count":13,"is_preprint":false},{"pmid":"17010329","id":"PMC_17010329","title":"CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation.","date":"2006","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17010329","citation_count":13,"is_preprint":false},{"pmid":"23736536","id":"PMC_23736536","title":"CRYAB modulates the activation of CD4+ T cells from relapsing-remitting multiple sclerosis patients.","date":"2013","source":"Multiple sclerosis (Houndmills, Basingstoke, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23736536","citation_count":13,"is_preprint":false},{"pmid":"38660406","id":"PMC_38660406","title":"The activation of LBH-CRYAB signaling promotes cardiac protection against I/R injury by inhibiting apoptosis and ferroptosis.","date":"2024","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/38660406","citation_count":12,"is_preprint":false},{"pmid":"31226261","id":"PMC_31226261","title":"αB-crystallin (CRYAB) regulates the proliferation, apoptosis, synthesis and degradation of extracellular matrix of chondrocytes in osteoarthritis.","date":"2019","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/31226261","citation_count":12,"is_preprint":false},{"pmid":"31244750","id":"PMC_31244750","title":"Anti-inflammatory and Oto-Protective Effect of the Small Heat Shock Protein Alpha B-Crystallin (HspB5) in Experimental Pneumococcal Meningitis.","date":"2019","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31244750","citation_count":12,"is_preprint":false},{"pmid":"32533979","id":"PMC_32533979","title":"Effect of cataract-associated mutations in the N-terminal domain of αB-crystallin (HspB5).","date":"2020","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/32533979","citation_count":11,"is_preprint":false},{"pmid":"26475352","id":"PMC_26475352","title":"Induction and phosphorylation of the small heat shock proteins HspB1/Hsp25 and HspB5/αB-crystallin in the rat retina upon optic nerve injury.","date":"2016","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/26475352","citation_count":11,"is_preprint":false},{"pmid":"35333698","id":"PMC_35333698","title":"The crystallin alpha B (HSPB5)-tripartite motif containing 33 (TRIM33) axis mediates myocardial fibrosis induced by angiotensinogen II through transforming growth factor-β (TGF-β1)-Smad3/4 signaling.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35333698","citation_count":11,"is_preprint":false},{"pmid":"34520490","id":"PMC_34520490","title":"Analysis of amyloid-like secondary structure in the Cryab-R120G knock-in mouse model of hereditary cataracts by two-dimensional infrared spectroscopy.","date":"2021","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/34520490","citation_count":11,"is_preprint":false},{"pmid":"36388803","id":"PMC_36388803","title":"Role of methylation-related genes CRYAB and SLC39A11 in the occurrence and development of lung adenocarcinoma.","date":"2022","source":"Annals of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36388803","citation_count":9,"is_preprint":false},{"pmid":"18473830","id":"PMC_18473830","title":"HspB5/alphaB-crystallin: properties and current progress in neuropathy.","date":"2008","source":"Current neurovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/18473830","citation_count":9,"is_preprint":false},{"pmid":"31037987","id":"PMC_31037987","title":"Adipocyte abundances of CES1, CRYAB, ENO1 and GANAB are modified in-vitro by glucose restriction and are associated with cellular remodelling during weight regain.","date":"2019","source":"Adipocyte","url":"https://pubmed.ncbi.nlm.nih.gov/31037987","citation_count":9,"is_preprint":false},{"pmid":"34041241","id":"PMC_34041241","title":"Long Noncoding RNA lnc-TSSK2-8 Activates Canonical Wnt/β-Catenin Signaling Through Small Heat Shock Proteins HSPA6 and CRYAB.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34041241","citation_count":9,"is_preprint":false},{"pmid":"31757032","id":"PMC_31757032","title":"Radiation-Stimulated Translocation of CD166 and CRYAB to the Endothelial Surface Provides Potential Vascular Targets on Irradiated Brain Arteriovenous Malformations.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31757032","citation_count":9,"is_preprint":false},{"pmid":"40377988","id":"PMC_40377988","title":"Activation mechanism of small heat shock protein HSPB5 revealed by disease-associated mutants.","date":"2025","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/40377988","citation_count":8,"is_preprint":false},{"pmid":"36204880","id":"PMC_36204880","title":"Effects of the CRYAB gene on stem cell-like properties of colorectal cancer and its mechanism.","date":"2022","source":"Journal of cancer research and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/36204880","citation_count":8,"is_preprint":false},{"pmid":"33220080","id":"PMC_33220080","title":"HspB5/αB-crystallin phosphorylation at S45 and S59 is essential for protection of the dendritic tree of rat hippocampal neurons.","date":"2020","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33220080","citation_count":8,"is_preprint":false},{"pmid":"28640093","id":"PMC_28640093","title":"Correlations of single nucleotide polymorphisms of CRYAA and CRYAB genes with the risk and clinicopathological features of children suffering from congenital cataract.","date":"2017","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28640093","citation_count":8,"is_preprint":false},{"pmid":"23602713","id":"PMC_23602713","title":"Characterization of migration parameters on peripheral and central nervous system T cells following treatment of experimental allergic encephalomyelitis with CRYAB.","date":"2013","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/23602713","citation_count":8,"is_preprint":false},{"pmid":"39561005","id":"PMC_39561005","title":"Mutation of CRYAB encoding a conserved mitochondrial chaperone and antiapoptotic protein causes hereditary optic atrophy.","date":"2024","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/39561005","citation_count":7,"is_preprint":false},{"pmid":"32650630","id":"PMC_32650630","title":"Phosphorylation of the Chaperone-Like HspB5 Rescues Trafficking and Function of F508del-CFTR.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32650630","citation_count":7,"is_preprint":false},{"pmid":"34887920","id":"PMC_34887920","title":"PIK3R1, SPNB2, and CRYAB as Potential Biomarkers for Patients with Diabetes and Developing Acute Myocardial Infarction.","date":"2021","source":"International journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/34887920","citation_count":7,"is_preprint":false},{"pmid":"37713608","id":"PMC_37713608","title":"Identification of CryAB as a target of NUAK kinase activity in Drosophila muscle tissue.","date":"2023","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37713608","citation_count":6,"is_preprint":false},{"pmid":"37259327","id":"PMC_37259327","title":"HSPB5 Inhibition by NCI-41356 Reduces Experimental Lung Fibrosis by Blocking TGF-β1 Signaling.","date":"2023","source":"Pharmaceuticals (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/37259327","citation_count":6,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52504,"output_tokens":8152,"usd":0.139896,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17810,"output_tokens":8404,"usd":0.149575,"stage2_stop_reason":"end_turn"},"total_usd":0.289471,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2015,\n      \"finding\": \"A conserved histidine (His-104) in the ACD dimer interface of HSPB5 controls oligomer structure and chaperone activity in response to acidosis. Destabilization by pH or His-104 mutation shifts the ACD from dimer to monomer and expands oligomer states, producing constitutively activated holdase chaperones that reorganize into structurally distinct client-bound complexes.\",\n      \"method\": \"In vitro biochemical assays, mutagenesis, structural analysis of dimer interface, chaperone activity assays across pH range\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutagenesis and structural characterization, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"25962097\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HSPB5 wild-type exists in reversible nonactivated (low activity) and activated (high activity) states; disease mutants R120G and D109H are constitutively activated chaperones. The disordered N-terminal regions (NTR) are sequestered from solvent in nonactivated states; mutation or acidic pH causes rearrangements that expose the NTR to enable client binding. Constitutive NTR exposure in mutants leads to increased coaggregation propensity and early cataract.\",\n      \"method\": \"Hydrogen-deuterium exchange mass spectrometry, native mass spectrometry, chaperone activity assays, mutagenesis of R120G and D109H variants\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal biophysical methods plus mutagenesis and functional assays in a single rigorous study\",\n      \"pmids\": [\"40377988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Under non-stress conditions, wild-type HSPB5 delays client aggregation solely through transient interactions early in the aggregation pathway, whereas HSPB5 mutants mimicking stress-activated states can also intervene at later aggregation stages, demonstrating state-dependent mechanistic differences in chaperone engagement.\",\n      \"method\": \"In vitro chaperone activity assays with α-lactalbumin as client, comparison of WT and stress-mimicking mutants under varying conditions\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reconstitution with defined client, single lab\",\n      \"pmids\": [\"30567736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The R120G mutant CryAB forms toxic amyloid oligomers (~240–480 kDa) detected by anti-oligomer antibody, whereas wild-type forms only high-molecular-mass species. HSP22 and HSP25 directly interrupt oligomer formation by CryAB R120G; blockade of oligomer formation recovered ubiquitin-proteasomal activity and cellular viability in cardiomyocytes.\",\n      \"method\": \"In vitro recombinant protein assay, native PAGE, anti-oligomer immunoreactivity, adenoviral transfection in cardiomyocytes, proteasome activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution plus cell-based validation with multiple orthogonal methods\",\n      \"pmids\": [\"17092938\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"HSPB1 (Hsp27) selectively degrades aggregate-prone CryAB mutants (R120G, 450delA, 464delCT) via the ubiquitin-proteasome system. Evidence includes: proteasome inhibitor accumulates mutants; R120G and 450delA accumulate ubiquitin conjugates; HSPB1 knockdown increases polyubiquitin conjugates; HSPB1 overexpression rescue of 464delCT is blocked by proteasome inhibition.\",\n      \"method\": \"Co-expression in H9c2 cells, HSPB1 overexpression/knockdown, proteasome inhibitor treatment, ubiquitin conjugate detection by immunoblot\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — four independent lines of evidence in cell-based system, single lab\",\n      \"pmids\": [\"20863832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Co-expression of HSPB1, HSPB4, or HSPB5 itself most effectively prevents aggregation of three HSPB5 mutants (R120G, 450ΔA, 464ΔCT) by competitive incorporation into hetero-oligomers, negating dominant-negative effects; Hsp70 co-expression did not reduce aggregation, indicating the mechanism is oligomer-based rather than general chaperone activity.\",\n      \"method\": \"Systematic co-expression of all HSPB family members with HSPB5 mutants, aggregation scoring in cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — systematic cell-based screen with defined mutants, single lab\",\n      \"pmids\": [\"25961584\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HSF1 regulates p53 protein stability through alphaB-crystallin: hsf1−/− and alphaBcry−/− cells accumulate p53 due to reduced alphaB-crystallin levels. Immunoprecipitated p53R175H from wild-type MEFs pulls down both alphaB-crystallin and Fbx4 ubiquitin ligase, and ectopic Fbx4 increases p53R175H degradation in a mechanism requiring alphaB-crystallin.\",\n      \"method\": \"Co-immunoprecipitation of p53 with alphaB-crystallin and Fbx4, knockout MEF cell lines, ectopic Fbx4 expression, p53 stability assays\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal pulldown plus genetic KO validation, single lab\",\n      \"pmids\": [\"19343786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CRYAB associates with both E-cadherin and β-catenin at the cadherin/catenin adherens junction; the alpha-crystallin core domain mediates these interactions. CRYAB overexpression inhibits E-cadherin cytoplasmic internalization and maintains β-catenin at the membrane, reducing downstream cyclin-D1 and c-myc expression.\",\n      \"method\": \"Co-immunoprecipitation of endogenous E-cadherin and β-catenin with ectopic and recombinant CRYAB; domain mapping; NPC xenograft tumor suppression assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP with domain mapping and in vivo tumor suppression, single lab\",\n      \"pmids\": [\"22158051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CRYAB physically interacts with β-catenin and protects it from ubiquitination and proteasomal degradation, thereby stabilizing β-catenin and promoting canonical Wnt signaling to enhance osteogenic differentiation of human BMSCs.\",\n      \"method\": \"Co-immunoprecipitation, in vitro ubiquitination assay, luciferase reporter for Wnt activity, CRYAB overexpression/knockdown in BMSCs, in vivo bone formation assay\",\n      \"journal\": \"Cell proliferation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus in vitro ubiquitination assay and functional rescue, single lab\",\n      \"pmids\": [\"31638302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CRYAB interacts with ferritin heavy chain 1 (FTH1) and maintains FTH1 protein stability via the proteasome mechanism in a lactylation-dependent manner; CRYAB knockdown boosts FTH1 degradation, increases cellular iron and ROS, promoting ferroptosis and reducing osteogenic differentiation of BMSCs.\",\n      \"method\": \"IP-MS to identify CRYAB-interacting proteins, co-immunoprecipitation of CRYAB and FTH1, qRT-PCR, Western blot, ferroptosis assays (Fe/ROS levels, cell viability)\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with mechanistic follow-up on proteasomal degradation and lactylation, single lab\",\n      \"pmids\": [\"38787373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CRYAB interacts with STAT3 and upon sinomenine treatment undergoes nuclear translocation in astrocytes, where it inhibits STAT3 activation and DNA-binding activity, suppressing neuroinflammation downstream of DRD2.\",\n      \"method\": \"Co-immunoprecipitation of CRYAB with STAT3, electrophoretic mobility shift assay (EMSA) for STAT3 DNA binding, immunofluorescence for nuclear translocation, siRNA knockdown of DRD2 and CRYAB in primary astrocytes\",\n      \"journal\": \"Journal of neuroinflammation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus EMSA plus localization experiments, single lab\",\n      \"pmids\": [\"27724964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CRYAB suppresses IKKβ-mediated canonical NF-κB signaling by inhibiting IKK complex formation in intestinal epithelial cells. CRYAB overexpression suppresses pro-inflammatory cytokines (TNF-α, IL-6, IL-1β, IL-8); CRYAB deletion markedly enhances inflammatory responses; TAT-CRYAB fusion protein protects intestinal barrier integrity in colitis models.\",\n      \"method\": \"Lentiviral overexpression and CRISPR/Cas9 knockout, Western blot for IKK complex, cytokine measurement, in vivo DSS/TNBS colitis with TAT-CRYAB treatment\",\n      \"journal\": \"Mucosal immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic gain/loss-of-function with defined signaling readout and in vivo rescue, single lab\",\n      \"pmids\": [\"31481750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"αB-crystallin (HspB5) enhances TNF-α-induced NF-κB signaling in endothelial cells, increasing expression of adhesion molecules ICAM-1, VCAM-1, and E-selectin; αB-crystallin-deficient endothelial cells display elevated IκB and incomplete IκB degradation upon TNF-α stimulation, resulting in reduced leukocyte rolling in vivo.\",\n      \"method\": \"Ectopic expression in endothelial cells, endothelial cells from αB-crystallin-deficient mice, IκB level measurement, in vivo leukocyte rolling assay\",\n      \"journal\": \"Angiogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout plus gain-of-function with defined signaling and in vivo phenotype, single lab\",\n      \"pmids\": [\"23929007\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Phosphorylation negatively regulates exosomal secretion of cryAB: nonphosphorylated cryAB is preferentially packaged into exosomes, whereas a triple phosphomimetic (3-SD) mutant forms large cytosolic inclusions and shows decreased colocalization with MVE/exosome markers CD63 and Rab27. O-GlcNAcylation of cryAB is required for its exosomal packaging.\",\n      \"method\": \"YFP-tagged phosphomimetic construct transfection, colocalization with CD63/Rab27 by confocal microscopy, exosome isolation and immunoblot\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphomimetic mutagenesis plus organelle colocalization, single lab\",\n      \"pmids\": [\"26620801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Drosophila CryAB accumulates at Z-bands and around myonuclei, contains a conserved actin-binding domain, and physically interacts with the actin crosslinker Cheerio (filamin) as shown by mass spectrometry and co-immunoprecipitation. CryAB attenuation causes myonuclear clustering and altered sarcomeric actin/Cheerio patterns. Expression of CryAB(R120G) in Drosophila muscle disrupts myofibrillar integrity, produces Z-band breaks, reduces muscle performance, and causes cardiac arrhythmia.\",\n      \"method\": \"Mass spectrometry, co-immunoprecipitation, muscle-specific RNAi knockdown, transgenic expression of R120G mutant, confocal imaging of sarcomere structure, muscle performance and cardiac phenotype assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — MS identification + Co-IP validation + genetic loss-of-function + disease-mutant phenotype, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"25715399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NUAK kinase phosphorylates Drosophila CryAB at two previously unidentified serine residues conserved in human CryAB sequence. NUAK and CryAB interact physically (yeast 2-hybrid). Loss of NUAK catalytic function causes CryAB aggregation in muscle tissue; a phospho-mimetic NUAK promotes CryAB phosphorylation; mutation of these serines abolishes phosphorylation.\",\n      \"method\": \"CRISPR kinase-dead mutation, yeast 2-hybrid, phospho-mimetic NUAK construct, phosphosite mutagenesis, in vivo muscle phenotype assay\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast 2-hybrid physical interaction, kinase-dead and phosphosite mutagenesis with in vivo phenotype, single lab\",\n      \"pmids\": [\"37713608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CryAB protects mechanical (contractile/diastolic) properties of the heart while HSPB2 protects cardiac energetic balance. In genetically modified mice expressing only CryAB (DKO/mCryAB-Tg), ischemia/reperfusion caused impaired ATP/PCr recovery and massive energy wasting upon inotropic stimulation, whereas CryAB-alone hearts showed protection against diastolic dysfunction.\",\n      \"method\": \"Genetic mouse models (DKO, mCryAB transgenic, DKO/mCryAB-Tg), isolated heart ischemia/reperfusion, 31P NMR spectroscopy of cardiac energetics, contractile performance measurement\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple genetic mouse models with physiological measurements and NMR spectroscopy, distinct roles dissected rigorously\",\n      \"pmids\": [\"17846079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CRYAB translocates from cytoplasm to nucleus under heat stress and co-localizes with aggregated F-actin, reducing F-actin aggregation. CRYAB overexpression significantly reduces caspase-3-mediated apoptosis in cardiomyocytes exposed to heat stress.\",\n      \"method\": \"Stable CRYAB-overexpressing H9C2 cell lines, immunofluorescence for CRYAB localization and F-actin, cleaved-caspase 3 Western blot, flow cytometry for apoptosis\",\n      \"journal\": \"Cell stress & chaperones\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct localization experiment with functional consequence, single lab\",\n      \"pmids\": [\"30246229\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"αB-crystallin (HspB5) inhibits intracellular aggregation of α-synuclein when overexpressed in Neuro-2a cells, demonstrated using bicistronic constructs that uncouple sHsp expression from fluorescent tagging to avoid oligomeric structure artifacts.\",\n      \"method\": \"Bicistronic expression plasmids in Neuro-2a cells, quantification of α-syn inclusion-containing cells by fluorescence microscopy\",\n      \"journal\": \"Cell stress & chaperones\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — cell-based assay with careful construct design, single lab\",\n      \"pmids\": [\"28337642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Oxysterol VP1-001 stereoselectively binds to the cryAB dimer (demonstrated by differential scanning fluorimetry and microscale thermophoresis); its enantiomer ent-VP1-001 does not bind and has no therapeutic effect on lens opacity, establishing that stereoselective binding to cryAB dimers is required for reversal of lens opacity in R120G mutant and aged mice.\",\n      \"method\": \"In silico docking, differential scanning fluorimetry (DSF), microscale thermophoresis (MST), topical treatment of cataract mouse models, transmission electron microscopy\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro binding assays (DSF + MST) combined with in vivo functional stereoselectivity test, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"31369034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CRYAB mutation p.E105K reduces interaction with cytochrome c and voltage-dependent anion channel (VDAC) as shown by co-immunoprecipitation, impairs OXPHOS assembly and activity, promotes apoptosis, and causes retinal ganglion cell degeneration. Cryab-deficient mice display elevated apoptosis and mitochondrial dysfunctions, establishing CRYAB as a mitochondrial chaperone with antiapoptotic activity in RGCs.\",\n      \"method\": \"Co-immunoprecipitation of p.E105K mutant and WT CRYAB with cytochrome c and VDAC, OXPHOS complex activity assays, apoptosis assays, Cryab-knockin and knockout mice with retinal phenotyping\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP interaction mapping + OXPHOS assays + two mouse models, single lab\",\n      \"pmids\": [\"39561005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BRG1 (SWI/SNF ATPase) activates the CRYAB promoter through a 30 bp response element at the edge of a positioned nucleosome; HMGA1 proteins bind an AT-rich sequence within this element both in vitro and in vivo, and HMGA1 target sequences and HMGA1 proteins are required for maximal BRG1-mediated CRYAB promoter activation.\",\n      \"method\": \"Promoter deletion analysis, chromatin immunoprecipitation (ChIP) for HMGA1 binding in vivo, in vitro binding assay, luciferase reporter assay\",\n      \"journal\": \"DNA and cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP in vivo plus in vitro binding plus functional promoter analysis, single lab\",\n      \"pmids\": [\"17723105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"KLF4 transcription factor directly binds the CRYAB promoter and upregulates CRYAB expression in osteosarcoma cells, promoting cell proliferation and migration via CRYAB.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) of KLF4 at CRYAB promoter, luciferase reporter assay, KLF4 overexpression/knockdown with CRYAB expression measurement\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — ChIP plus reporter assay, single lab\",\n      \"pmids\": [\"27105535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HSPB5 interacts with SMAD4 and this interaction promotes SMAD4 canonical nuclear translocation in TGF-β1 signaling; chemical inhibitor NCI-41356 reduces HSPB5/SMAD4 interaction and blocks SMAD4 nuclear translocation, reducing pulmonary fibrosis markers in vitro and in vivo.\",\n      \"method\": \"Co-immunoprecipitation of HSPB5 with SMAD4, immunofluorescence for SMAD4 nuclear translocation, bleomycin mouse model with NCI-41356 treatment, collagen quantification\",\n      \"journal\": \"Pharmaceuticals (Basel, Switzerland)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP of interaction + functional inhibitor blocking nuclear translocation + in vivo rescue, single lab\",\n      \"pmids\": [\"37259327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Phosphorylation of HspB5 at S45 and S59 (but not S19) is essential for its ability to increase dendritic complexity; non-phosphorylatable HspB5-AAA fails to protect dendrites, while phosphomimetic HspB5-AEE (S45E/S59E-like) recapitulates the wild-type effect both in vitro and in vivo (in utero electroporation).\",\n      \"method\": \"Overexpression of phospho-mutant and phosphomimetic HspB5 constructs in cultured hippocampal neurons and in vivo via in utero electroporation, Sholl analysis of dendritic morphology\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphosite mutagenesis with in vitro and in vivo dendritic morphology readout, single lab\",\n      \"pmids\": [\"27085702\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In vitro, HspB5 forms hetero-oligomeric complexes with HspB1 and HspB4; subunit exchange kinetics are faster between HspB5 and HspB1 than between HspB5 and HspB4; the resulting hetero-complexes have distinct structural organization, stability, and chaperone-like activities compared to homo-oligomers.\",\n      \"method\": \"Biochemical reconstitution, small-angle X-ray scattering (SAXS), subunit exchange kinetics assay, chaperone activity assays\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reconstitution with biophysical characterization, single lab\",\n      \"pmids\": [\"22210387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HSPB5 and HSPB1 interact with lipid membranes differently; the alpha-crystallin domain of HSPB5 is embedded within liposomes as identified by proteinase K protection followed by mass spectrometry, suggesting the alpha-crystallin domain mediates membrane interaction relevant to non-classical secretion.\",\n      \"method\": \"Liposome binding assay, proteinase K protection experiment, mass spectrometry of protected membrane-embedded domains\",\n      \"journal\": \"Cell stress & chaperones\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reconstitution with liposomes plus MS domain mapping, single lab\",\n      \"pmids\": [\"31338686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The 343delT HSPB5 mutant protein is extremely insoluble and does not accumulate to detectable levels in iPSC-derived skeletal myotubes and cardiomyocytes; co-expression of wild-type HSPB5 rescues 343delT solubility both in vitro and in cells through direct interaction, supporting a loss-of-function model for the recessive myopathy.\",\n      \"method\": \"iPSC-derived patient cells (homozygous and gene-corrected heterozygous), BHK21 cells lacking HSPB5, in vitro refolding assay, co-immunoprecipitation of WT and 343delT\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patient-derived iPSCs plus in vitro reconstitution, Co-IP interaction, single lab\",\n      \"pmids\": [\"27226619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CRYAB (HSPB5) is identified as a senescence-induced survival gene; chemical inhibition of CRYAB by 25-hydroxycholesterol (25HC) induces senolysis in mouse and human senescent cells in culture and in vivo in mouse skeletal muscle.\",\n      \"method\": \"Single-cell RNA sequencing to identify CRYAB as senescence-induced gene, chemical inhibitor screening, validation in multiple cell types and in vivo mouse skeletal muscle\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — scRNA-seq target identification + in vitro/in vivo pharmacological validation, single lab\",\n      \"pmids\": [\"35198901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"LBH transcription factor upregulates CRYAB expression; the LBH-CRYAB signaling axis inhibits both mitochondrial apoptosis and ferroptosis in cardiomyocytes during I/R injury, with p53 identified as a mutual downstream effector for both death pathways.\",\n      \"method\": \"Pharmacological inhibitors, ectopic expression vectors, LBH/CRYAB knockout mouse models, apoptosis and ferroptosis assays in I/R injury model\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — knockout mouse models with defined pathway placement, single lab\",\n      \"pmids\": [\"38660406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CRYAB suppresses the IKKβ-mediated canonical NF-κB pathway (but not the IKKα noncanonical path) in hepatic ischemia/reperfusion injury. CRYAB also activates M2 macrophage polarization through Akt1/mTOR signaling, alleviating liver IRI.\",\n      \"method\": \"Western blot and immunofluorescence for IKKβ/IKKα pathway components, Akt1/mTOR pathway analysis, miR-450b-5p inhibition to restore CRYAB, in vivo hepatic IRI mouse model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway dissection with multiple readouts in cell and animal models, single lab\",\n      \"pmids\": [\"32532961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A phosphomimetic form of HspB5 (but not wild-type or non-phosphorylatable forms) increases plasma membrane trafficking, function, and stability of F508del-CFTR, with effects further enhanced by CFTR corrector/potentiator drugs.\",\n      \"method\": \"Phosphomimetic and non-phosphorylatable HspB5 mutant expression in cell lines, CFTR surface biotinylation, electrophysiology (CFTR function), co-immunoprecipitation\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phospho-mutagenesis with functional CFTR assays, single lab\",\n      \"pmids\": [\"32650630\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CRYAB (αB-crystallin/HSPB5) is an ATP-independent 'holdase' molecular chaperone that exists in reversible nonactivated and activated oligomeric states controlled by N-terminal region (NTR) accessibility and dimer-interface integrity; disease-associated mutations (R120G, D109H) or acidic pH constitutively expose the NTR to enable client binding, while wild-type HSPB5 uses pH-sensing at a conserved His-104 to toggle chaperone activity. Beyond protein quality control, CRYAB protects cytoskeletal integrity by interacting with actin crosslinkers (filamin/Cheerio) and F-actin, maintains cardiac mechanical function, inhibits caspase-mediated apoptosis and ferroptosis through interactions with cytochrome c/VDAC and stabilization of FTH1, modulates NF-κB signaling by inhibiting IKKβ, suppresses STAT3 activity via nuclear co-localization, stabilizes β-catenin against ubiquitin-proteasomal degradation to promote Wnt signaling, and facilitates degradation of client proteins (including p53 mutants) through interaction with the Fbx4 ubiquitin ligase. Phosphorylation at Ser45/Ser59 modulates its dendritic protective function, while phosphorylation at Ser59 inhibits its non-classical secretion via exosomes.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CRYAB (αB-crystallin/HSPB5) is an ATP-independent small heat-shock protein chaperone whose 'holdase' activity is gated by reversible transitions between low-activity nonactivated and high-activity activated oligomeric states, controlled by accessibility of the disordered N-terminal region and integrity of the α-crystallin domain (ACD) dimer interface [#1]. A conserved histidine (His-104) in the ACD dimer interface senses acidosis: its destabilization or mutation shifts the ACD from dimer toward monomer, expands oligomers, and produces constitutively activated holdase complexes [#0], while disease mutants R120G and D109H mimic this constitutive NTR exposure and raise coaggregation propensity [#1]. CRYAB delays client aggregation through transient early-pathway interactions in the nonactivated state and engages later aggregation stages once activated [#2], and it suppresses aggregation of clients including α-synuclein [#18] and itself forms hetero-oligomers with HSPB1/HSPB4 via subunit exchange to modulate activity [#25]. Aggregation-prone CRYAB mutants (R120G, frameshift variants) form toxic amyloid oligomers that are countered by other small HSPs through competitive hetero-oligomer incorporation and ubiquitin-proteasomal clearance [#3, #4, #5]. Beyond protein quality control, CRYAB preserves cytoskeletal and sarcomeric integrity through a conserved actin-binding domain and physical interaction with the filamin/Cheerio actin crosslinker [#14], translocates to the nucleus under heat stress to reduce F-actin aggregation and caspase-3 apoptosis [#17], and protects cardiac contractile/diastolic mechanical function [#16]. It acts as an antiapoptotic mitochondrial chaperone by interacting with cytochrome c and VDAC to support OXPHOS assembly [#20] and limits ferroptosis by stabilizing ferritin heavy chain FTH1 against proteasomal degradation [#9]. CRYAB modulates multiple signaling pathways: it stabilizes β-catenin against ubiquitination to promote canonical Wnt signaling [#7, #8], inhibits IKKβ-mediated canonical NF-κB signaling [#11, #30], suppresses STAT3 DNA-binding activity upon nuclear translocation [#10], promotes SMAD4 nuclear translocation in TGF-β1 signaling [#23], and supports degradation of mutant p53 via the Fbx4 ubiquitin ligase under HSF1 control [#6]. Phosphorylation at Ser45/Ser59 is required for its dendrite-protective function [#24], while phosphorylation negatively regulates its O-GlcNAcylation-dependent non-classical secretion via exosomes [#13]. Recessive loss-of-function (343delT) causes myopathy through protein insolubility rescuable by wild-type co-expression [#27], and CRYAB function is therapeutically targetable by stereoselective small-molecule binding to its dimer to reverse cataract [#19].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Established that CRYAB protects the specifically mechanical (contractile/diastolic) properties of the heart, distinguishing its in vivo physiological role from energetic protection by HSPB2.\",\n      \"evidence\": \"Genetic mouse models (DKO, mCryAB transgenic) with ischemia/reperfusion, 31P NMR cardiac energetics, contractile measurement\",\n      \"pmids\": [\"17846079\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis linking chaperone activity to mechanical protection not defined\", \"Does not identify the cardiac client proteins involved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed CRYAB acts as a degradation cofactor by linking mutant p53 to the Fbx4 ubiquitin ligase, connecting chaperone function to targeted proteolysis under HSF1 control.\",\n      \"evidence\": \"Reciprocal Co-IP of p53R175H with CRYAB and Fbx4, hsf1-/- and alphaBcry-/- MEFs, ectopic Fbx4 stability assays\",\n      \"pmids\": [\"19343786\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether CRYAB is a general adaptor for Fbx4 substrates unknown\", \"Structural basis of the p53-CRYAB-Fbx4 ternary interaction not resolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined that the disease mutant R120G forms toxic amyloid oligomers and that other small HSPs can interrupt this to restore proteostasis and viability.\",\n      \"evidence\": \"Recombinant protein assays, native PAGE, anti-oligomer antibody, adenoviral cardiomyocyte expression, proteasome activity assay\",\n      \"pmids\": [\"17092938\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic structure of the toxic oligomer not determined\", \"How HSP22/HSP25 physically block oligomerization unresolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated that aggregate-prone CRYAB mutants are cleared by the ubiquitin-proteasome system, with HSPB1 directing this degradation.\",\n      \"evidence\": \"Co-expression in H9c2 cells, HSPB1 overexpression/knockdown, proteasome inhibitor, ubiquitin conjugate immunoblot\",\n      \"pmids\": [\"20863832\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase mediating mutant ubiquitination not identified\", \"Selectivity for mutant over wild-type not mechanistically explained\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Mapped CRYAB engagement of adherens junctions, showing its core domain binds E-cadherin and β-catenin to retain β-catenin at the membrane and suppress Wnt target genes.\",\n      \"evidence\": \"Reciprocal Co-IP of endogenous E-cadherin/β-catenin with CRYAB, domain mapping, NPC xenograft assay\",\n      \"pmids\": [\"22158051\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reconciliation with later report that CRYAB promotes Wnt signaling not addressed\", \"Direct vs indirect nature of the β-catenin interaction not fully separated\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed CRYAB forms hetero-oligomers with HSPB1 and HSPB4 with distinct exchange kinetics and chaperone activities, establishing oligomeric plasticity as a regulatory feature.\",\n      \"evidence\": \"Biochemical reconstitution, SAXS, subunit exchange kinetics, chaperone activity assays\",\n      \"pmids\": [\"22210387\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo stoichiometry of hetero-oligomers unknown\", \"Functional consequences in tissue not tested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Revealed a context-dependent role in NF-κB signaling, where CRYAB enhances TNF-α-induced NF-κB and adhesion molecule expression in endothelium.\",\n      \"evidence\": \"Ectopic expression and αB-crystallin-deficient endothelial cells, IκB measurement, in vivo leukocyte rolling\",\n      \"pmids\": [\"23929007\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Opposite (inhibitory) effect on NF-κB in epithelial contexts not reconciled\", \"Direct molecular target in the NF-κB cascade not identified here\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified transcriptional control of CRYAB by BRG1/SWI-SNF acting through a nucleosome-positioned response element requiring HMGA1.\",\n      \"evidence\": \"Promoter deletion, ChIP for HMGA1 in vivo, in vitro binding, luciferase reporter\",\n      \"pmids\": [\"17723105\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological stimuli driving this regulation not defined\", \"Tissue specificity of the element unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined His-104 in the ACD dimer interface as a pH sensor that toggles oligomer state and holdase activity, providing a structural basis for stress-activation.\",\n      \"evidence\": \"In vitro biochemistry, mutagenesis, dimer-interface structural analysis, pH-range chaperone assays\",\n      \"pmids\": [\"25962097\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In-cell relevance of His-104 pH sensing not demonstrated\", \"Identity of physiological clients of the activated state not mapped\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Established the conserved actin/sarcomere role: CryAB localizes to Z-bands and binds the filamin orthologue Cheerio, and R120G disrupts myofibrillar integrity in vivo.\",\n      \"evidence\": \"Mass spectrometry, Co-IP, muscle RNAi, transgenic R120G expression, sarcomere imaging, cardiac phenotyping in Drosophila\",\n      \"pmids\": [\"25715399\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct F-actin vs filamin contribution not fully separated\", \"Whether human CRYAB binds filamin in muscle not directly tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showed phosphorylation negatively regulates non-classical exosomal secretion of CryAB, with O-GlcNAcylation required for packaging.\",\n      \"evidence\": \"YFP phosphomimetic constructs, CD63/Rab27 colocalization, exosome isolation and immunoblot\",\n      \"pmids\": [\"26620801\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinase responsible in this context not identified\", \"Functional role of secreted CryAB not addressed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated that Ser45/Ser59 phosphorylation is specifically required for CRYAB-mediated enhancement of dendritic complexity.\",\n      \"evidence\": \"Phospho-mutant/phosphomimetic constructs in hippocampal neurons and in utero electroporation, Sholl analysis\",\n      \"pmids\": [\"27085702\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking phosphorylation to dendrite morphology unknown\", \"Relevant client/cytoskeletal effectors not identified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Placed CRYAB in anti-inflammatory signaling as a STAT3 partner that translocates to the nucleus and blocks STAT3 DNA binding.\",\n      \"evidence\": \"Co-IP with STAT3, EMSA, immunofluorescence, siRNA of DRD2/CRYAB in astrocytes\",\n      \"pmids\": [\"27724964\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs scaffold-mediated inhibition of STAT3 unresolved\", \"How nuclear translocation is triggered not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified KLF4 as a direct transcriptional activator of CRYAB driving osteosarcoma proliferation and migration.\",\n      \"evidence\": \"ChIP at CRYAB promoter, luciferase reporter, KLF4 gain/loss with CRYAB readout\",\n      \"pmids\": [\"27105535\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream CRYAB effectors in tumor cells not mapped\", \"Generality across cancers untested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Supported a recessive loss-of-function disease model by showing the 343delT mutant is insoluble and rescued in solubility by direct interaction with wild-type CRYAB.\",\n      \"evidence\": \"Patient iPSC-derived myotubes/cardiomyocytes, HSPB5-null BHK21 cells, in vitro refolding, Co-IP\",\n      \"pmids\": [\"27226619\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Native fold/structure of 343delT not characterized\", \"Tissue-specific thresholds for pathology unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Confirmed CRYAB suppresses intracellular aggregation of α-synuclein, extending its anti-aggregation chaperone activity to a neurodegeneration-relevant client.\",\n      \"evidence\": \"Bicistronic constructs in Neuro-2a cells, quantification of α-syn inclusions\",\n      \"pmids\": [\"28337642\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether interaction is direct and stoichiometric not shown\", \"In vivo neuronal relevance not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolved state-dependent chaperone mechanism: nonactivated WT acts only early in aggregation, while activated mutant forms can also intervene at late stages.\",\n      \"evidence\": \"In vitro chaperone assays with α-lactalbumin, WT vs stress-mimicking mutants\",\n      \"pmids\": [\"30567736\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single defined client limits generalization\", \"Structural snapshots of late-stage engagement absent\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linked nuclear translocation under heat stress to cytoskeletal protection and apoptosis suppression in cardiomyocytes.\",\n      \"evidence\": \"Stable CRYAB-overexpressing H9C2 cells, immunofluorescence of CRYAB/F-actin, cleaved caspase-3, flow cytometry\",\n      \"pmids\": [\"30246229\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nuclear import mechanism unknown\", \"Direct vs indirect effect on caspase-3 unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Reframed the CRYAB-β-catenin interaction as protective, stabilizing β-catenin against ubiquitination to promote Wnt-driven osteogenesis.\",\n      \"evidence\": \"Co-IP, in vitro ubiquitination, Wnt luciferase reporter, gain/loss in BMSCs, in vivo bone formation\",\n      \"pmids\": [\"31638302\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Contradiction with adherens-junction sequestration model not reconciled\", \"Mechanism by which CRYAB blocks β-catenin ubiquitination undefined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined CRYAB inhibition of canonical NF-κB by blocking IKK complex formation, with anti-inflammatory protection in colitis models.\",\n      \"evidence\": \"Lentiviral overexpression and CRISPR knockout, IKK complex immunoblot, cytokine assays, TAT-CRYAB in DSS/TNBS colitis\",\n      \"pmids\": [\"31481750\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct CRYAB-IKKβ binding not structurally shown\", \"Reconciliation with endothelial pro-NF-κB role missing\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed the ACD mediates direct membrane interaction by embedding within liposomes, a feature relevant to non-classical secretion.\",\n      \"evidence\": \"Liposome binding, proteinase K protection, MS of protected domains\",\n      \"pmids\": [\"31338686\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Membrane topology in cells not confirmed\", \"Link to a specific secretion route not established\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established CRYAB dimers as a druggable target, with stereoselective oxysterol binding required to reverse lens opacity.\",\n      \"evidence\": \"In silico docking, DSF, MST, topical treatment of R120G and aged cataract mice, TEM\",\n      \"pmids\": [\"31369034\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Co-structure of CRYAB-ligand complex not solved\", \"Whether binding reactivates physiological chaperone function unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Extended NF-κB suppression to hepatic I/R injury and added Akt1/mTOR-driven M2 macrophage polarization as a parallel protective mechanism.\",\n      \"evidence\": \"IKKβ/IKKα pathway immunoblot/IF, Akt1/mTOR analysis, miR-450b-5p inhibition, in vivo hepatic IRI\",\n      \"pmids\": [\"32532961\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether macrophage effect is cell-autonomous or secreted-CRYAB mediated unclear\", \"Direct IKKβ engagement not shown structurally\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed phosphomimetic HspB5 enhances plasma membrane trafficking and stability of F508del-CFTR, indicating phosphorylation-state-dependent client handling.\",\n      \"evidence\": \"Phospho-mutant expression, CFTR surface biotinylation, electrophysiology, Co-IP\",\n      \"pmids\": [\"32650630\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct CRYAB-CFTR binding interface undefined\", \"In vivo relevance to cystic fibrosis untested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified CRYAB as a senescence-induced survival gene whose chemical inhibition triggers senolysis.\",\n      \"evidence\": \"Single-cell RNA-seq, chemical inhibitor (25HC), in vitro/in vivo skeletal muscle validation\",\n      \"pmids\": [\"35198901\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular survival pathway protected by CRYAB in senescent cells not defined\", \"Selectivity of 25HC for CRYAB incomplete\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Connected HSPB5 to TGF-β1 signaling by promoting SMAD4 nuclear translocation, with druggable disruption reducing fibrosis.\",\n      \"evidence\": \"Co-IP with SMAD4, SMAD4 nuclear IF, NCI-41356 inhibitor, bleomycin mouse model, collagen quantification\",\n      \"pmids\": [\"37259327\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether interaction is direct unconfirmed\", \"Mechanism of SMAD4 import facilitation unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified NUAK kinase as an upstream regulator phosphorylating conserved serines on CryAB to prevent its aggregation in muscle.\",\n      \"evidence\": \"CRISPR kinase-dead mutation, yeast 2-hybrid, phospho-mimetic NUAK, phosphosite mutagenesis, Drosophila muscle phenotype\",\n      \"pmids\": [\"37713608\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct in vitro phosphorylation by NUAK not shown\", \"Whether human NUAK phosphorylates human CRYAB at these sites untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined CRYAB as a mitochondrial antiapoptotic chaperone binding cytochrome c and VDAC to support OXPHOS, with a disease mutation impairing these interactions.\",\n      \"evidence\": \"Co-IP of WT and p.E105K with cytochrome c/VDAC, OXPHOS activity assays, Cryab knock-in/knockout mouse retinal phenotyping\",\n      \"pmids\": [\"39561005\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether CRYAB resides inside mitochondria or at the outer membrane unresolved\", \"Stoichiometry of cytochrome c/VDAC binding undefined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showed CRYAB stabilizes ferritin heavy chain FTH1 against proteasomal degradation in a lactylation-dependent manner to suppress ferroptosis.\",\n      \"evidence\": \"IP-MS, Co-IP of CRYAB-FTH1, knockdown with Fe/ROS and ferroptosis assays in BMSCs\",\n      \"pmids\": [\"38787373\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How lactylation controls the interaction mechanistically unclear\", \"Whether CRYAB directly blocks FTH1 ubiquitination untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Placed CRYAB in a LBH-CRYAB axis that inhibits both apoptosis and ferroptosis through a shared p53 effector in cardiac I/R injury.\",\n      \"evidence\": \"Inhibitors, ectopic expression, LBH/CRYAB knockout mice, apoptosis and ferroptosis assays\",\n      \"pmids\": [\"38660406\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct CRYAB-p53 regulation in this context not mapped\", \"Mechanism converging two death pathways on p53 unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CRYAB's reversible oligomeric activation state is selectively coupled to its many divergent and sometimes opposite client and signaling functions in vivo remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking activation state to specific client/pathway selection\", \"Opposing NF-κB and Wnt effects across tissues not mechanistically reconciled\", \"Atomic structures of client-bound activated complexes lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [0, 1, 2, 18, 27]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [3, 9, 8, 20]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [14, 17]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [10, 11, 23]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [6, 7, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [13, 17]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [10, 17]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [14, 17]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [7, 26, 31]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [3, 4, 6, 9]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [17, 20, 29]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8, 10, 11, 23, 30]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [0, 1, 17]},\n      {\"term_id\": \"R-HSA-397014\", \"supporting_discovery_ids\": [14, 16]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"FTH1\", \"VDAC\", \"CYCS\", \"CTNNB1\", \"STAT3\", \"SMAD4\", \"FLNA\", \"HSPB1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}